<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>American Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9297</issn>
<issn pub-type="epub">1537-6605</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31402090</article-id>
<article-id pub-id-type="pmc">6731360</article-id>
<article-id pub-id-type="publisher-id">S0002-9297(19)30268-X</article-id>
<article-id pub-id-type="doi">10.1016/j.ajhg.2019.07.005</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>De Novo</italic> Missense Variants in <italic>FBXW11</italic> Cause Diverse Developmental Phenotypes Including Brain, Eye, and Digit Anomalies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="au1">
<name>
<surname>Holt</surname>
<given-names>Richard J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="fn" rid="fn1">26</xref>
</contrib>
<contrib contrib-type="author" id="au2">
<name>
<surname>Young</surname>
<given-names>Rodrigo M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="fn" rid="fn1">26</xref>
</contrib>
<contrib contrib-type="author" id="au3">
<name>
<surname>Crespo</surname>
<given-names>Berta</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="fn" rid="fn1">26</xref>
</contrib>
<contrib contrib-type="author" id="au4">
<name>
<surname>Ceroni</surname>
<given-names>Fabiola</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="fn" rid="fn1">26</xref>
</contrib>
<contrib contrib-type="author" id="au5">
<name>
<surname>Curry</surname>
<given-names>Cynthia J.</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author" id="au6">
<name>
<surname>Bellacchio</surname>
<given-names>Emanuele</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author" id="au7">
<name>
<surname>Bax</surname>
<given-names>Dorine A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au8">
<name>
<surname>Ciolfi</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author" id="au9">
<name>
<surname>Simon</surname>
<given-names>Marleen</given-names>
</name>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author" id="au10">
<name>
<surname>Fagerberg</surname>
<given-names>Christina R.</given-names>
</name>
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author" id="au11">
<name>
<surname>van Binsbergen</surname>
<given-names>Ellen</given-names>
</name>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author" id="au12">
<name>
<surname>De Luca</surname>
<given-names>Alessandro</given-names>
</name>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author" id="au13">
<name>
<surname>Memo</surname>
<given-names>Luigi</given-names>
</name>
<xref ref-type="aff" rid="aff10">10</xref>
</contrib>
<contrib contrib-type="author" id="au14">
<name>
<surname>Dobyns</surname>
<given-names>William B.</given-names>
</name>
<xref ref-type="aff" rid="aff11">11</xref>
<xref ref-type="aff" rid="aff12">12</xref>
</contrib>
<contrib contrib-type="author" id="au15">
<name>
<surname>Mohammed</surname>
<given-names>Alaa Afif</given-names>
</name>
<xref ref-type="aff" rid="aff13">13</xref>
<xref ref-type="aff" rid="aff14">14</xref>
</contrib>
<contrib contrib-type="author" id="au16">
<name>
<surname>Clokie</surname>
<given-names>Samuel J.H.</given-names>
</name>
<xref ref-type="aff" rid="aff13">13</xref>
</contrib>
<contrib contrib-type="author" id="au17">
<name>
<surname>Zazo Seco</surname>
<given-names>Celia</given-names>
</name>
<xref ref-type="aff" rid="aff15">15</xref>
</contrib>
<contrib contrib-type="author" id="au18">
<name>
<surname>Jiang</surname>
<given-names>Yong-Hui</given-names>
</name>
<xref ref-type="aff" rid="aff16">16</xref>
</contrib>
<contrib contrib-type="author" id="au19">
<name>
<surname>Sørensen</surname>
<given-names>Kristina P.</given-names>
</name>
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author" id="au20">
<name>
<surname>Andersen</surname>
<given-names>Helle</given-names>
</name>
<xref ref-type="aff" rid="aff17">17</xref>
</contrib>
<contrib contrib-type="author" id="au21">
<name>
<surname>Sullivan</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="aff18">18</xref>
</contrib>
<contrib contrib-type="author" id="au22">
<name>
<surname>Powis</surname>
<given-names>Zöe</given-names>
</name>
<xref ref-type="aff" rid="aff19">19</xref>
</contrib>
<contrib contrib-type="author" id="au23">
<name>
<surname>Chassevent</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff20">20</xref>
</contrib>
<contrib contrib-type="author" id="au24">
<name>
<surname>Smith-Hicks</surname>
<given-names>Constance</given-names>
</name>
<xref ref-type="aff" rid="aff20">20</xref>
</contrib>
<contrib contrib-type="author" id="au25">
<name>
<surname>Petrovski</surname>
<given-names>Slavé</given-names>
</name>
<xref ref-type="aff" rid="aff21">21</xref>
<xref ref-type="aff" rid="aff22">22</xref>
</contrib>
<contrib contrib-type="author" id="au26">
<name>
<surname>Antoniadi</surname>
<given-names>Thalia</given-names>
</name>
<xref ref-type="aff" rid="aff13">13</xref>
</contrib>
<contrib contrib-type="author" id="au27">
<name>
<surname>Shashi</surname>
<given-names>Vandana</given-names>
</name>
<xref ref-type="aff" rid="aff18">18</xref>
</contrib>
<contrib contrib-type="author" id="au28">
<name>
<surname>Gelb</surname>
<given-names>Bruce D.</given-names>
</name>
<xref ref-type="aff" rid="aff23">23</xref>
</contrib>
<contrib contrib-type="author" id="au29">
<name>
<surname>Wilson</surname>
<given-names>Stephen W.</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author" id="au30">
<name>
<surname>Gerrelli</surname>
<given-names>Dianne</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author" id="au31">
<name>
<surname>Tartaglia</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author" id="au32">
<name>
<surname>Chassaing</surname>
<given-names>Nicolas</given-names>
</name>
<xref ref-type="aff" rid="aff15">15</xref>
<xref ref-type="aff" rid="aff24">24</xref>
</contrib>
<contrib contrib-type="author" id="au33">
<name>
<surname>Calvas</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="aff15">15</xref>
<xref ref-type="aff" rid="aff24">24</xref>
</contrib>
<contrib contrib-type="author" id="au34">
<name>
<surname>Ragge</surname>
<given-names>Nicola K.</given-names>
</name>
<email>nragge@brookes.ac.uk</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff25">25</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Faculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, UK</aff>
<aff id="aff2"><label>2</label>Department of Cell and Developmental Biology, Biosciences, University College London, Gower St, London WC1E 6BT, UK</aff>
<aff id="aff3"><label>3</label>Institute of Ophthalmology, University College London, 11-34 Bath Street, London EC1V 9EL, UK</aff>
<aff id="aff4"><label>4</label>Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK</aff>
<aff id="aff5"><label>5</label>Genetic Medicine, University of California, San Francisco/Fresno, Fresno, CA 93701, USA</aff>
<aff id="aff6"><label>6</label>Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Scientific Institute for Research, Hospitalization, and Healthcare, 00146 Rome, Italy</aff>
<aff id="aff7"><label>7</label>Department of Genetics, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands</aff>
<aff id="aff8"><label>8</label>Department of Clinical Genetics, Odense University Hospital, 5000 Odense C, Denmark</aff>
<aff id="aff9"><label>9</label>Molecular Genetics Unit, Fondazione Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy</aff>
<aff id="aff10"><label>10</label>Unità Operativa Complessa di Pediatria e Patologia Neonatale, Ospedale San Martino, 32100 Belluno, Italy</aff>
<aff id="aff11"><label>11</label>University of Washington, Seattle, WA 98195-6320, USA</aff>
<aff id="aff12"><label>12</label>Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle WA 98101, USA</aff>
<aff id="aff13"><label>13</label>West Midlands Regional Genetics Laboratory, Birmingham Women’s and Children’s National Health Service Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2TG, UK</aff>
<aff id="aff14"><label>14</label>Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, 11562 Cairo, Egypt</aff>
<aff id="aff15"><label>15</label>UDEAR, Université de Toulouse, UMRS 1056 Institut National de la Santé et de la Recherche Médicale-Université Paul Sabatier, 31059 Toulouse, France</aff>
<aff id="aff16"><label>16</label>Department of Pediatrics and Neurobiology, Program in Genetics and Genomics, Duke University School of Medicine, Durham, NC 27710, USA</aff>
<aff id="aff17"><label>17</label>Hans Christian Andersen Children’s Hospital, Odense University Hospital, 5000 Odense C, Odense, Denmark</aff>
<aff id="aff18"><label>18</label>Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC 27710, USA</aff>
<aff id="aff19"><label>19</label>Department of Clinical Affairs, Ambry Genetics, Aliso Viejo, CA 92656, USA</aff>
<aff id="aff20"><label>20</label>Department of Neurology, Division of Neurogenetics Kennedy Krieger Institute, Baltimore, MD 21205, USA</aff>
<aff id="aff21"><label>21</label>Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&amp;D, AstraZeneca, Cambridge, CB4 0WG, UK</aff>
<aff id="aff22"><label>22</label>Department of Medicine, the University of Melbourne, Melbourne, VIC 3010, Australia</aff>
<aff id="aff23"><label>23</label>Mindich Child Health and Development Institute, Department of Pediatrics, and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</aff>
<aff id="aff24"><label>24</label>Department of Medical Genetics, Purpan University Hospital, 31059 Toulouse, France</aff>
<aff id="aff25"><label>25</label>West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women’s and Children’s National Health Service Foundation Trust, Birmingham, B15 2TG, UK</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>nragge@brookes.ac.uk</email></corresp>
<fn id="fn1">
<label>26</label>
<p id="ntpara0010">These authors contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>05</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>8</month>
<year>2019</year>
</pub-date>
<volume>105</volume>
<issue>3</issue>
<fpage>640</fpage>
<lpage>657</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Authors</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<p>The identification of genetic variants implicated in human developmental disorders has been revolutionized by second-generation sequencing combined with international pooling of cases. Here, we describe seven individuals who have diverse yet overlapping developmental anomalies, and who all have <italic>de novo</italic> missense <italic>FBXW11</italic> variants identified by whole exome or whole genome sequencing and not reported in the gnomAD database. Their phenotypes include striking neurodevelopmental, digital, jaw, and eye anomalies, and in one individual, features resembling Noonan syndrome, a condition caused by dysregulated RAS signaling. <italic>FBXW11</italic> encodes an F-box protein, part of the Skp1-cullin-F-box (SCF) ubiquitin ligase complex, involved in ubiquitination and proteasomal degradation and thus fundamental to many protein regulatory processes. FBXW11 targets include β-catenin and GLI transcription factors, key mediators of Wnt and Hh signaling, respectively, critical to digital, neurological, and eye development. Structural analyses indicate affected residues cluster at the surface of the loops of the substrate-binding domain of FBXW11, and the variants are predicted to destabilize the protein and/or its interactions. <italic>In situ</italic> hybridization studies on human and zebrafish embryonic tissues demonstrate <italic>FBXW11</italic> is expressed in the developing eye, brain, mandibular processes, and limb buds or pectoral fins. Knockdown of the zebrafish <italic>FBXW11</italic> orthologs <italic>fbxw11a</italic> and <italic>fbxw11b</italic> resulted in embryos with smaller, misshapen, and underdeveloped eyes and abnormal jaw and pectoral fin development. Our findings support the role of <italic>FBXW11</italic> in multiple developmental processes, including those involving the brain, eye, digits, and jaw.</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>FBXW11</kwd>
<kwd>brain</kwd>
<kwd>neurodevelopment</kwd>
<kwd>eye</kwd>
<kwd>WD40</kwd>
<kwd>digit</kwd>
<kwd>development</kwd>
<kwd>hedgehog</kwd>
<kwd>Wnt</kwd>
<kwd>Noonan syndrome</kwd>
</kwd-group>
</article-meta>
<notes>
<p id="misc0010">Published: August 8, 2019</p>
</notes>
</front>
<body>
<sec id="sec1">
<title>Main Text</title>
<p id="p0010">Whole exome or whole genome sequencing (WES and WGS, respectively) has dramatically advanced the identification of genetic variants contributing to complex, rare, and clinically heterogeneous human disorders. However, because such variants might be private, it can be challenging to ascribe pathogenicity. Recently, WES and WGS and the international collation of affected individuals with variants in the same gene<xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib2">2</xref> have led to the identification of several developmental disorders. This approach, referred to as “reverse phenotyping,” has been successfully applied to multiple intellectual disability syndromes, including those related to genetic variants in <italic>FBXO11</italic> (MIM: <ext-link ext-link-type="omim" id="intref0010" xlink:href="607871">607871</ext-link>),<xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref> and syndromes involving variants in <italic>CDC42</italic> (MIM: <ext-link ext-link-type="omim" id="intref0015" xlink:href="116952">116952</ext-link>) and <italic>RAC1</italic> (MIM: <ext-link ext-link-type="omim" id="intref0020" xlink:href="602048">602048</ext-link>),<xref ref-type="bibr" rid="bib6">6</xref>, <xref ref-type="bibr" rid="bib7">7</xref> all of which display clinical heterogeneity. Here, we use a similar approach to investigate the role of <italic>de novo</italic> variants in <italic>FBXW11</italic> (MIM: <ext-link ext-link-type="omim" id="intref0025" xlink:href="605651">605651</ext-link>) in human development.</p>
<p id="p0015">Through WES of 32 individuals with developmental eye anomalies, we identified a <italic>de novo</italic> missense variant (GenBank: NM_012300.2:c.1087C&gt;T; NP_036432:p.Arg363Trp) in <italic>FBXW11</italic>. This variant was present in a girl with striking eye anomalies (bilateral microanterior segments, iris and chorioretinal coloboma, and lens anomalies), digital anomalies, and a psychiatric disorder (individual 1) (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="table" rid="tbl1">Tables 1</xref> and <xref ref-type="supplementary-material" rid="mmc1">S1</xref>, and the <xref ref-type="supplementary-material" rid="mmc1">Supplemental Note</xref>). No other pathogenic variants were present in known eye development genes. Koolen et al.<xref ref-type="bibr" rid="bib8"><sup>8</sup></xref> previously described a boy with holoprosencephaly (HPE), seizures, small stature, preaxial polydactyly affecting the hand, “finger-like thumbs,” and an increased sandal gap who had a <italic>de novo</italic> duplication encompassing seven genes, including <italic>FBXW11,</italic> on chromosome 5q35.1 (1.24 Mb). They hypothesized that his phenotype could be explained by the duplication of <italic>FBXW11</italic>, given its putative role in hedgehog (Hh) signaling and the phenotypic overlap with other disorders (HPE and polydactyly) caused by dysregulation of this pathway. Furthermore, duplication of the homologous gene <italic>BTRC</italic> (MIM: <ext-link ext-link-type="omim" id="intref0030" xlink:href="603482">603482</ext-link>) is implicated in split hand-foot malformation.<xref ref-type="bibr" rid="bib9"><sup>9</sup></xref> Moreover, FBXW11 participates in the Wnt/β-catenin signaling pathway,<xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref> which is fundamentally important in eye and brain development<xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref> and digit patterning.<xref ref-type="bibr" rid="bib14"><sup>14</sup></xref><fig id="fig1"><label>Figure 1</label><caption><p>Phenotypes of Individuals 1, 2, 4, 5, and 7</p><p>(A–C) Individual 1 at age 13 years, showing bilateral ptosis related to the underlying ocular anomalies (A), contractures affecting the distal interphalangeal joints of the left 4<sup>th</sup> and 5<sup>th</sup> fingers (B), and a wide sandal gap, short terminal phalanges, contractures affecting the 4<sup>th</sup> and 5<sup>th</sup> toes, 2–3 toe syndactyly, and scarring from surgery removing the left supernumerary toe (C).</p><p>(D–I) Individual 1 at age 24 years, showing bilateral microanterior segment and iris colobomas (D–G), contractures of the 4<sup>th</sup> and 5<sup>th</sup> left fingers (H), scarring from surgery removing the supernumerary toe, 2–3 toe syndactyly, and contractures of the 4<sup>th</sup> and 5<sup>th</sup> toes (I).</p><p>(J–O) Individual 2 at age 9 years, showing a prominent nasal tip, broad columella, and retrognathia (J–K), the feet showing contractures (see the detailed view of the left 2<sup>nd</sup> toe), short distal digits, widely spaced toes, left 2–3 toe syndactyly, right 2<sup>nd</sup> toe clinodactyly (L and M) comparable to that of Individual 1, and MRI scans revealing an abnormal corpus callosum, an absent splenium, thick Probst bundles, small globular dysplastic hippocampi, and mildly reduced white matter volume (N and O).</p><p>(P–W) Individual 4 at age 18 years, showing dysmorphic facial features including mild ptosis of the upper eyelids, malar hypoplasia, a long and smooth philtrum, a bifid nasal tip, a thin upper lip (P), micrognathia, a tall sloping forehead, and small ears (Q); digital anomalies include shortening of the distal phalanx of the thumbs, 5<sup>th</sup> finger clinodactyly (R–U), thenar hypoplasia on the right (S), and mild thenar hypoplasia on the left (U); digital anomalies of the feet include shortening of the distal phalanx of the toes and increased convexity of all toenails (V and W).</p><p>(X–AB) Individual 5 at 4 months, showing a small chin (X), adducted thumbs not well shown as they are held by the clinician (Y and Z), and normal feet (AA and AB).</p><p>(AC) Individual 7 at 3 years and 2 months, showing frontal bossing; a deep, broad nasal bridge, epicanthus; low-set, posteriorly rotated ears; and a large, protruding tongue.</p><p>(AD–AJ) Individual 7 at 9 years and 8 months, showing frontal bossing; a deep, broad nasal bridge; epicanthus; low-set, posteriorly rotated ears (AD and AE); mild prognathism (AE); pectus carinatum (AF); and bilateral clinodactyly of the 4<sup>th</sup> and 5<sup>th</sup> toes (AG and AH). Brain MRI of Individual 7 showed complete agenesis of the corpus callosum with only a small residual portion of the anterior genum, a retro-cerebellar arachnoidal cyst (AI), and colpocephaly characterized by dilated lateral ventricles, specifically in the occipital and temporal horns and the third ventricle (AJ).</p></caption><graphic xlink:href="gr1"></graphic></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Summary of Phenotypic and Genotypic Data of Individuals with <italic>FBXW11</italic> Missense Variants</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2"><bold>Individual</bold></th><th><bold>1</bold></th><th><bold>2</bold></th><th><bold>3</bold></th><th><bold>4</bold></th><th><bold>5</bold></th><th><bold>6</bold></th><th><bold>7</bold></th><th><bold>Koolen et al. 2006</bold><xref ref-type="bibr" rid="bib8"><sup>8</sup></xref></th></tr></thead><tbody><tr><td colspan="2">Variant (GenBank: <ext-link ext-link-type="uri" id="intref0230" xlink:href="ncbi-n:NM_012300.2">NM_012300.2</ext-link>; NP_036432.2)</td><td>c.1087C&gt;T (p.Arg363Trp)</td><td>c.1091C&gt;A (p.Ala364Asp)</td><td>c.1093G&gt;A (p.Ala365Thr)</td><td>c.1330G&gt;A (p.Glu444Lys)</td><td>c.1340G&gt;A (p.Arg447Gln)</td><td>c.1340G&gt;T (p.Arg447Leu)</td><td>c.724G&gt;C (p.Gly242Arg)</td><td><ext-link ext-link-type="uri" id="intref0235" xlink:href="ncbi-tnm:1">1</ext-link>.24Mb duplication</td></tr><tr><td colspan="2">gnomAD<xref ref-type="bibr" rid="bib26"><sup>26</sup></xref> frequency</td><td>absent</td><td>absent</td><td>absent</td><td>absent</td><td>absent</td><td>absent</td><td>absent</td><td>N/A</td></tr><tr><td colspan="2">Inheritance</td><td><italic>de novo</italic></td><td><italic>de novo</italic></td><td><italic>de novo</italic></td><td><italic>de novo</italic></td><td><italic>de novo</italic></td><td><italic>de novo</italic></td><td><italic>de novo</italic></td><td><italic>de novo</italic></td></tr><tr><td colspan="2">InterVar<xref ref-type="bibr" rid="bib77"><sup>77</sup></xref> classification</td><td>likely pathogenic</td><td>likely pathogenic</td><td>likely pathogenic</td><td>likely pathogenic</td><td>likely pathogenic</td><td>likely pathogenic</td><td>likely pathogenic</td><td>N/A</td></tr><tr><td colspan="2">SIFT<xref ref-type="bibr" rid="bib78"><sup>78</sup></xref> classification</td><td>damaging</td><td>tolerated</td><td>damaging</td><td>damaging</td><td>damaging</td><td>tolerated</td><td>damaging</td><td>N/A</td></tr><tr><td colspan="2">PolyPhen-2<xref ref-type="bibr" rid="bib79"><sup>79</sup></xref> classification</td><td>probably damaging</td><td>probably damaging</td><td>probably damaging</td><td>possibly damaging</td><td>probably damaging</td><td>probably damaging</td><td>probably damaging</td><td>N/A</td></tr><tr><td colspan="2">Sex</td><td>female</td><td>male</td><td>male</td><td>female</td><td>female</td><td>male</td><td>male</td><td>male</td></tr><tr><td rowspan="2">Birth parameters</td><td>Term (weeks [+days])</td><td>40 (+5)</td><td>40</td><td>40 (+2)</td><td>39</td><td>40 (+6)</td><td>38</td><td>38</td><td>N/A</td></tr><tr><td>Weight (kg)</td><td>4.08</td><td>3.63</td><td>3.95</td><td>3.15</td><td>3.17</td><td>3.40</td><td>3.22</td><td>N/A</td></tr><tr><td rowspan="4">Growth parameters (age)</td><td>Current age (years)</td><td>24</td><td>9</td><td>27</td><td>18</td><td>1</td><td>8</td><td>9 years, 7 months</td><td>19</td></tr><tr><td>Weight in kg (%ile)</td><td>54 (34<sup>th</sup> %)</td><td>33.2 (79<sup>th</sup> %)</td><td>75 (68<sup>th</sup> %)</td><td>37.5 (0.1<sup>st</sup> %; −3.7 SD)</td><td>6.2 (0.1<sup>st</sup> %; −3.5 SD)</td><td>30.2 (82<sup>nd</sup> %)</td><td>24.5 (8<sup>th</sup> %)</td><td>N/A</td></tr><tr><td>Height in cm (%ile)</td><td>169 (81<sup>st</sup> %)</td><td>138.4 (81<sup>st</sup> %)</td><td>180 (68<sup>th</sup> %)</td><td>146.2 (0.5<sup>th</sup> %; −2.5 SD)</td><td>66 (2<sup>nd</sup> %; −2.1 SD)</td><td>134.5 (86<sup>th</sup> %)</td><td>123.5 (2<sup>nd</sup> %; −2.1 SD)</td><td>157 (5.5<sup>th</sup> %) (at 15 years)</td></tr><tr><td>Head circumference in cm (%ile)</td><td>58.4 (&gt;99<sup>th</sup> %; +3.7 SD)</td><td>53 (64<sup>th</sup> %)</td><td>55.5 (61<sup>st</sup> %)</td><td>48.5 (&lt;1<sup>st</sup> %; −5.5 SD)<xref ref-type="table-fn" rid="tblfn1">a</xref></td><td>N/A</td><td>57 (&gt;99<sup>th</sup> %; +3.5 SD)</td><td>56 (99<sup>th</sup> %)</td><td>57 (92<sup>nd</sup> %) (at 15 years)</td></tr><tr><td rowspan="8">Congenital anomalies</td><td>Facial</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td></tr><tr><td>Mandibular</td><td>retrognathia</td><td>retrognathia</td><td>no</td><td>micrognathia</td><td>retrognathia</td><td>no</td><td>mild prognathism</td><td>no</td></tr><tr><td>Ocular</td><td>bilateral microanterior segment, lens anomalies and colobomas, R microphthalmia</td><td>severe strabismus</td><td>mild myopia</td><td>no</td><td>alternating exotropia</td><td>no</td><td>mild myopia</td><td>no</td></tr><tr><td>Hand</td><td>contractures of the 4<sup>th</sup> and 5<sup>th</sup> fingers</td><td>thinning of R and L thenar musculature, short 5<sup>th</sup> metacarpal, R transverse palmar crease, and relative brachydactyly</td><td>no</td><td>thinning of thenar musculature R &gt; L and short distal phalanges of thumbs, bilateral mild 5<sup>th</sup> finger clinodactyly</td><td>no<xref ref-type="table-fn" rid="tblfn2">b</xref></td><td>no</td><td>brachydactyly, small hands</td><td>right preaxial polydactyly, finger-like thumbs</td></tr><tr><td>Foot</td><td>L middle toe polydactyly, wide sandal gaps, 2–3 toe syndactyly, contractures of the L 4<sup>th</sup> and 5<sup>th</sup> toes</td><td>mild 2–3 toe syndactyly, 2<sup>nd</sup> toe clinodactyly, brachydactyly, wide toe spacing, contractures of the 2<sup>nd</sup> and 4<sup>th</sup> toes, short 5<sup>th</sup> metatarsal</td><td>no</td><td>short terminal phalanges, wide sandal gaps</td><td>no</td><td>no</td><td>bilateral clinodactyly of the 4<sup>th</sup> and 5<sup>th</sup> toes, brachydactyly, small feet</td><td>wide sandal gaps</td></tr><tr><td>Cardiac</td><td>no</td><td>no</td><td>no</td><td>no</td><td>pulmonary stenosis</td><td>no</td><td>patent foramen ovale</td><td>ventricular septal defect</td></tr><tr><td>renal or urological</td><td>no</td><td>no</td><td>no</td><td>no</td><td>R renal hypoplasia</td><td>no</td><td>no</td><td>VUR</td></tr><tr><td>Skeletal</td><td>no</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>no</td><td>yes</td><td>no</td></tr><tr><td rowspan="3">Development</td><td>Motor delay</td><td>no</td><td>moderate</td><td>moderate</td><td>severe</td><td>severe</td><td>mild to moderate</td><td>severe</td><td>yes</td></tr><tr><td>Intellectual deficiency</td><td>no</td><td>moderate to severe</td><td>severe</td><td>severe</td><td>delayed milestones</td><td>moderate to severe</td><td>moderate to severe</td><td>mild</td></tr><tr><td>Speech and language delay</td><td>no</td><td>severe</td><td>severe</td><td>severe</td><td>N/A</td><td>moderate</td><td>moderate</td><td>N/A</td></tr><tr><td>Behavior</td><td>ASD or psychiatric features</td><td>psychiatric issues</td><td>repetitive behaviors</td><td>classic autism</td><td>hand stereotypy, self-injurious, impulsive and aggressive behavior</td><td>N/A</td><td>ASD, anxiety</td><td>self-injurious, impulsive and aggressive behavior</td><td>N/A</td></tr><tr><td rowspan="3">Neurological features</td><td>Tone</td><td>normal</td><td>increased</td><td>increased</td><td>narrow based gait</td><td>cerebral palsy</td><td>low</td><td>low</td><td>increased</td></tr><tr><td>Seizures or EEG activity</td><td>N/A</td><td>mild slowing of cerebral activity</td><td>normal</td><td>N/A</td><td>N/A</td><td>N/A</td><td>normal</td><td>infrequent seizures</td></tr><tr><td>MRI</td><td>N/A</td><td>hypoplasia of the corpus callosum, reduced white matter, abnormal hippocampi</td><td>N/A</td><td>normal</td><td>generalized white matter atrophy, periventricular white matter changes with ischemic damage</td><td>mild prominence of lateral ventricles</td><td>hypoplasia of the corpus callosum, mild prominence of lateral ventricles</td><td>lobar HPE, hypoplasia of the corpus callosum</td></tr><tr><td colspan="2">Other relevant findings</td><td>none</td><td>umbilical and inguinal hernias</td><td>none</td><td>hyperkinetic</td><td>circulatory collapse at few days of age</td><td>dermal melanosis, cupped ears</td><td>webbed neck, bilateral cryptorchidism</td><td>N/A</td></tr></tbody></table><table-wrap-foot><fn><p>Details of the previously reported individual with the 1.24Mb duplication<xref ref-type="bibr" rid="bib8"><sup>8</sup></xref> are included in a separate column for reference. Detailed information is provided in the <xref ref-type="supplementary-material" rid="mmc1">Supplemental Note</xref> and <xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>. The protein domains are reported according to UniProt annotations. All variants are absent from gnomAD. Variant locations are given according to GenBank: <ext-link ext-link-type="uri" id="intref0240" xlink:href="ncbi-n:NM_012300.2">NM_012300.2</ext-link> and NP_036432.2. Clinical interpretation of genetic variants according to ACMG/AMP 2015 guidelines was automatically predicted by InterVar for missense variants. Where available, information regarding inheritance was included in the InterVar prediction. Abbreviations are as follows: ASD = autism spectrum disorder; L = left; N/A = not available; R = right; and VUR = vesicoureteric reflux.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>a</label><p id="ntpara0015">Extreme microcephaly.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn2"><label>b</label><p id="ntpara0020">Adducted thumbs.</p></fn></table-wrap-foot></table-wrap></p>
<p id="p0020">Through GeneMatcher,<xref ref-type="bibr" rid="bib2"><sup>2</sup></xref> we identified six other individuals with <italic>de novo</italic> missense variants in <italic>FBXW11</italic>; all were predicted to be damaging and found by WES or WGS. Five individuals (individuals 2–6) exhibited neurodevelopmental and/or digit anomalies, and one (individual 7) had a complex phenotype including brain anomalies and features suggestive of Noonan syndrome (<xref ref-type="table" rid="tbl1">Tables 1</xref> and <xref ref-type="supplementary-material" rid="mmc2">S1</xref>, <xref ref-type="fig" rid="fig1">Figure 1</xref>, and the <xref ref-type="supplementary-material" rid="mmc1">Supplemental Note</xref>). Individual 7 had no pathogenic variants in genes currently included in Noonan syndrome or related RASopathy diagnostic panels. All genetic testing was performed under research ethics approval from the UK “Genetics of Eye and Brain anomalies” study (REC 04/Q0104/129), French (CPP Sud-Ouest and Outre-Mer II), American (Duke University, Pro00032301 - Genomic Study of Medical, Developmental, or Congenital Problems of Unknown Etiology), and Italian (Ospedale Pediatrico Bambino Gesù study 1702_OPBG_2018) ethics committees or by clinical diagnostic consent (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Material and Methods</xref>).</p>
<p id="p0025">Our seven individuals presented with a range of overlapping phenotypes. Neurodevelopmental features commonly included neurodevelopmental delay (6/7), speech delay (5/7), autistic and/or stereotypical behaviors (3/7), psychiatric features (4/7), and micro- (1/7) or macrocephaly (3/7). MRI data from five individuals indicated corpus callosal hypoplasia (2/5), dilated ventricles (2/5), and white matter atrophy (2/5). Five of seven individuals had an under- or overdeveloped jaw. Digital anomalies were striking and included brachydactyly or short distal phalanges (3/7), polysyndactyly (2/7), widened interdigital spaces and/or sandal gap (2/7), camptodactyly or contractures (2/7), and underdeveloped thenar musculature (2/7). Individual 7 was clinically diagnosed with Noonan syndrome, and pulmonary stenosis, a recurrent feature of this disorder, was present in individual 5. Only individual 1 had developmental eye anomalies. Certain of these phenotypes overlap with those of the boy, presented by Koolen et al.,<xref ref-type="bibr" rid="bib8"><sup>8</sup></xref> who exhibited multiple digital anomalies, neurodevelopmental delay, and absence of the anterior part of the corpus callosum. From the published images, it also appears that he has broad halluces and short terminal phalanges. The latter are interesting because individual 4 had bilateral shortening of the thumbs and big toes, individuals 2, 4, and 7 had short terminal phalanges and/or brachydactyly, and individuals 2 and 4 had underdevelopment of the thenar eminence, akin to “finger-like thumbs.” Although overlapping features can be seen, there is phenotypic diversity, which appears to be an emerging pattern for variants affecting genes controlling multiple cellular pathways and developmental processes; these gene include, for example, <italic>CDC42</italic>,<xref ref-type="bibr" rid="bib6"><sup>6</sup></xref>
<italic>FBXO11</italic>,<xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref>
<italic>SHH</italic> (MIM: <ext-link ext-link-type="omim" id="intref0035" xlink:href="600725">600725</ext-link>),<xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib16">16</xref> and <italic>SOX2</italic> (MIM: <ext-link ext-link-type="omim" id="intref0040" xlink:href="184429">184429</ext-link>).<xref ref-type="bibr" rid="bib17">17</xref>, <xref ref-type="bibr" rid="bib18">18</xref></p>
<p id="p0030">FBXW11 belongs to a highly conserved group of around 60 proteins characterized by a motif of ∼40 amino acids (the F-box). This family is subdivided into three classes: FBXWs containing WD40 repeats, FBXLs containing leucine-rich repeats, and FBXOs containing either different protein-protein interaction modules or no recognizable motifs.<xref ref-type="bibr" rid="bib19"><sup>19</sup></xref> WD40-repeats are also a motif of approximately 40 amino acids and typically fold into a β-propeller structure that is involved in protein-protein interaction.<xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref> Alterations in other F-box genes, for example <italic>FBXO11</italic><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref> and <italic>FBXL4</italic> (MIM: <ext-link ext-link-type="omim" id="intref0045" xlink:href="605654">605654</ext-link>), have been associated with neurodevelopmental disorders.<xref ref-type="bibr" rid="bib22"><sup>22</sup></xref> FBXW11 is a substrate adaptor of the Skp1-cullin-F-box (SCF) ubiquitin ligase complex, which catalyzes phosphorylation-dependent ubiquitination.<xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib23">23</xref> It has several targets, including β-catenin and GLI transcription factors, key mediators of the Wnt and the Hh pathways, respectively. Despite the importance of these two pathways, little is known about the role of <italic>FBXW11</italic> in human development and the impact of aberrant FBXW11 function on human disease.</p>
<p id="p0035">Different <italic>in silico</italic> metrics indicate that <italic>FBXW11</italic> is moderately intolerant to variation.<xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref> It has a Residual Variation Intolerance Score (RVIS) of −0.47, ranking it among the 23% of human protein-coding genes most intolerant to functional (missense, nonsense, and splice) variants.<xref ref-type="bibr" rid="bib24"><sup>24</sup></xref> Moreover, metrics reported on gnomAD (v2.1.1)<xref ref-type="bibr" rid="bib26"><sup>26</sup></xref> suggest it is intolerant to both loss-of-function (LoF) variants (observed/expected [o/e] score = 0.15, 0.08–0.31 90% confidence interval [CI]; pLI score = 0.98) and missense variants (o/e score = 0.37, 0.32–0.43 90% CI; <italic>Z</italic> score = 3.96). The latter is of particular relevance because all the <italic>de novo</italic> variants in this study are missense changes. In addition to these seven variants, two further <italic>de novo</italic> changes of uncertain clinical significance in <italic>FBXW11</italic> have been reported in large scale studies of autism spectrum disorder (ASD) (GenBank: NM_012300.2:c.243C&gt;G [p.Asp81Glu]; dbSNP: rs995419585, c.508C&gt;T [p.Arg170Ter]).<xref ref-type="bibr" rid="bib27">27</xref>, <xref ref-type="bibr" rid="bib28">28</xref> None of these nine variants or other changes affecting these amino acids were listed on gnomAD, with the exception of a rare synonymous variant for Ala365 (dbSNP: rs775168567, GenBank: NM_012300.2:c.1095C&gt;T, minor allele frequency [MAF] = 0.00001771) and a missense change for Arg170 (dbSNP: rs995419585, GenBank: NM_012300.2:c.508C&gt;G [p.Arg170Gly], MAF = 0.000003984). Furthermore, the nucleotide positions affected by our seven missense variants are evolutionarily conserved according to the GERP rejected substitutions scores<xref ref-type="bibr" rid="bib29">29</xref>, <xref ref-type="bibr" rid="bib30">30</xref> (<xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>). Interestingly, these variants are located in regions depleted for nonsynonymous variation (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>). According to the model developed by Havrilla et al.,<xref ref-type="bibr" rid="bib31"><sup>31</sup></xref> six of the seven missense changes affect residues located within portions of the protein considered as under the highest constraint in the human genome, ranking among the top 5% constrained coding regions (CCRs). The amino acid substitution (c.724G&gt;C [p.Gly242Arg]) in individual 7, who presented with features of Noonan syndrome, is located in a region characterized by a slightly lower level of constraint (85<sup>th</sup> percentile). Therefore, the location of the variants in these regions further supports their potential relevance to protein function.</p>
<p id="p0040">Intriguingly, all seven missense variants affected the WD40 domain of FBXW11 (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In particular, six of the seven changes appeared to cluster at the N-terminal end of the WD4 (residues 363 to 365, in individuals 1, 2, and 3, affecting consecutive amino acids) and WD6 (residues 444 and 447, in individuals 4, 5, and 6 [individuals 5 and 6 had the same affected amino acid]) repeats. The seventh variant (in individual 7) affected the N-terminal end of the WD1 repeat. In contrast with this specific distribution, the two variants reported in the ASD-affected individuals<xref ref-type="bibr" rid="bib27">27</xref>, <xref ref-type="bibr" rid="bib28">28</xref> either affected a different domain of FBXW11 (p.Asp81Glu, homodimerization domain), or resulted in a truncated, likely inactive, protein (p.Arg170Ter).<fig id="fig2"><label>Figure 2</label><caption><p>Structural Modeling of <italic>FBXW11</italic> Missense Variants</p><p>(A) A schematic representation of FBXW11 showing the relative locations of the homodimerization domain D (Hd D, blue), F-box (red), WD40 domains (green), and the missense variants identified in our seven individuals.</p><p>(B) A Clustal Omega alignment of the FBXW11 regions containing the variants identified in this study showing affected amino acids highlighted in yellow and complete conservation across species.</p><p>(C) A homology model of FBXW11 in complex with Skp1 and β-catenin based on PDB structure PDB: <ext-link ext-link-type="uri" id="intref0225" xlink:href="pdb:1P22">1P22</ext-link>. Skp1 is shown in blue, β-catenin in orange, and the FBXW11 domains in red (F-box), green (linker region), and gray (WD40 domains).</p><p>(D) The locations of the amino acids affected by the <italic>FBXW11</italic> variants within the WD40 domain. β-catenin is shown in orange.</p><p>(E) The modeled WD40 domain of FBXW11 in complex with β-catenin (orange) and other available peptides known to bind FBXW7 or Cdc4 (cyclin E C-terminal degron, cyclin E N-terminal degron, DISC1, high-affinity CPD phosphopeptide from human cyclin E, SIC1).</p></caption><graphic xlink:href="gr2"></graphic></fig></p>
<p id="p0045">No protein structure for FBXW11 was available in the Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB).<xref ref-type="bibr" rid="bib32"><sup>32</sup></xref> However, an experimentally derived crystal structure for a homolog, BTRC, complexed with Skp1 and β-catenin was available (PDB: <ext-link ext-link-type="uri" id="intref0050" xlink:href="pdb:1P22">1P22</ext-link>).<xref ref-type="bibr" rid="bib20"><sup>20</sup></xref> Pairwise alignment of BTRC (GenBank: <ext-link ext-link-type="uri" id="intref0055" xlink:href="ncbi-p:NP_003930.1">NP_003930.1</ext-link>) and FBXW11 (GenBank: <ext-link ext-link-type="uri" id="intref0060" xlink:href="ncbi-p:NP_036432.2">NP_036432.2</ext-link>) show the proteins have 79.0% identity and 87.4% similarity, and the regions containing the missense variants in individuals 1–7 were highly conserved (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>). Therefore, we modeled a 3D structure for FBXW11 (GenBank: <ext-link ext-link-type="uri" id="intref0065" xlink:href="ncbi-p:NP_036432.2">NP_036432.2</ext-link>) based on the crystal structure of BTRC, employing a previously described procedure.<xref ref-type="bibr" rid="bib33"><sup>33</sup></xref> The location of the affected residues was visualized with PyMOL v2.0 (the PyMOL Molecular Graphics System, Version 2.0 Schrödinger). Notably, all affected residues were located toward the tips of the loops of the WD repeat domains, which are predicted to mediate substrate binding (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Because there is high conservation of the WD repeat structure, and because each repeat contacts β-catenin,<xref ref-type="bibr" rid="bib20"><sup>20</sup></xref> all seven altered residues are expected to impact substrate binding. Clustering of the <italic>de novo</italic> missense variants suggests an impact on protein function via gain-of-function or dominant-negative mechanisms.<xref ref-type="bibr" rid="bib34"><sup>34</sup></xref> Despite this, and the fact that the phenotypes of these individuals fall in broad, overlapping categories, there is variation in the specifics of their features. We modeled the WD40 domain of FBXW11 bound to substrates of the WD40-domain-containing proteins FBXW7 and Cdc4 (<xref ref-type="fig" rid="fig2">Figure 2</xref>E). This indicated that individual substrates might adopt different orientations when binding to FBXW11, suggesting a variable contribution of the different WD40 motifs in FBXW11 binding to individual ligands. Therefore, it is possible that the missense variants identified here might have varying impacts depending on the substrate.</p>
<p id="p0050">We investigated the impact of the missense variants on protein stability and interaction with Skp1 and β-catenin for both our modeled FBXW11 structure and BTRC by using FoldX.<xref ref-type="bibr" rid="bib35"><sup>35</sup></xref> Predictions indicated five of the seven missense variants (c.1087C&gt;T [p.Arg363Trp]; c.1091C&gt;A [p.Ala364Asp]; c.1093G&gt;A [p.Ala365Thr]; c.1340G&gt;A [p.Arg447Gln]; and c.724G&gt;C [p.Gly242Arg]) impact the stability of both FBXW11 and BTRC (<xref ref-type="table" rid="tbl2">Table 2</xref>). Furthermore, five of the variants (p.Ala364Asp, p.Ala365Thr, p.Arg447Gln, p.Arg447Leu, and p.Gly242Arg) were predicted to decrease the stability of the FBXW11-β-catenin and BTRC-β-catenin interactions. Three variants (p.Ala365Thr, p.Arg447Leu, and p.Gly242Arg) also decreased the stability of the FBXW11-Skp1 and BTRC-Skp1 interactions (<xref ref-type="table" rid="tbl2">Table 2</xref>). Interestingly, the variant (p.Gly242Arg) in individual 7, who presented with features of Noonan syndrome, was predicted to have the greatest impact on both FBXW11 and BTRC stability and their interactions with β-catenin and Skp1. On the basis of these analyses, the variants are predicted to produce variable downstream effects and resultant phenotypes, particularly because FBXW11 is involved in multiple developmental pathways.<table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>FoldX Predictions of the Impact on FBXW11 and BTRC Stability and Their Interactions with Skp1 and β-catenin of the <italic>FBXW11</italic> Variants Identified in Individuals 1–7</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3"><bold>Individual</bold><hr/></th><th><bold>1</bold><hr/></th><th><bold>2</bold><hr/></th><th><bold>3</bold><hr/></th><th><bold>4</bold><hr/></th><th><bold>5</bold><hr/></th><th><bold>6</bold><hr/></th><th><bold>7</bold><hr/></th></tr><tr><th colspan="3">Variant</th><th>p.Arg363Trp</th><th>p.Ala364Asp</th><th>p.Ala365Thr</th><th>p.Glu444Lys</th><th>p.Arg447Gln</th><th>p.Arg447Leu</th><th>p.Gly242Arg</th></tr></thead><tbody><tr><td rowspan="6">FBXW11</td><td rowspan="2">FBXW11</td><td>ΔΔG</td><td>0.521609</td><td>4.09086</td><td>4.12764</td><td>−0.0159721</td><td>1.63651</td><td>0.1246</td><td>12.0844</td></tr><tr><td>Stability</td><td>minor decrease</td><td>decrease</td><td>decrease</td><td>none</td><td>decrease</td><td>none</td><td>decrease</td></tr><tr><td rowspan="2">+ Skp1</td><td>ΔΔG</td><td>0.0</td><td>0.0</td><td>0.482</td><td>0.0</td><td>0.0</td><td>0.9022</td><td>9.6142</td></tr><tr><td>Stability</td><td>none</td><td>none</td><td>minor decrease</td><td>none</td><td>none</td><td>minor decrease</td><td>decrease</td></tr><tr><td rowspan="2">+ β-catenin</td><td>ΔΔG</td><td>0.12782</td><td>4.943962</td><td>3.866386</td><td>−0.37936</td><td>2.2931</td><td>1.55266</td><td>10.19112</td></tr><tr><td>Stability</td><td>none</td><td>decrease</td><td>decrease</td><td>none</td><td>decrease</td><td>decrease</td><td>decrease</td></tr><tr><td rowspan="6">BTRC</td><td rowspan="2">BTRC</td><td>ΔΔG</td><td>0.51728</td><td>4.47495</td><td>3.59842</td><td>−0.10002</td><td>1.54555</td><td>0.0186672</td><td>10.264</td></tr><tr><td>Stability</td><td>minor decrease</td><td>decrease</td><td>decrease</td><td>none</td><td>decrease</td><td>none</td><td>decrease</td></tr><tr><td rowspan="2">+ Skp1</td><td>ΔΔG</td><td>0.0</td><td>0.0</td><td>0.6572</td><td>0.0</td><td>0.0</td><td>0.7318</td><td>8.8664</td></tr><tr><td>Stability</td><td>none</td><td>none</td><td>minor decrease</td><td>none</td><td>none</td><td>minor decrease</td><td>decrease</td></tr><tr><td rowspan="2">+ β-catenin</td><td>ΔΔG</td><td>0.14382</td><td>5.78723</td><td>3.457756</td><td>−0.33198</td><td>2.279382</td><td>1.5214</td><td>9.16596</td></tr><tr><td>Stability</td><td>none</td><td>decrease</td><td>decrease</td><td>none</td><td>decrease</td><td>decrease</td><td>decrease</td></tr></tbody></table><table-wrap-foot><fn><p>ΔΔG provided as kcal mol<sup>-1</sup>. Values of ΔΔG greater than 0.46 kcal mol<sup>-1</sup> indicate a decrease in stability, whereas decreases greater than −0.46 kcal mol<sup>-1</sup> indicate an increase in stability. Mean values of ΔΔG for five replicate analyses of each variant are given.</p></fn></table-wrap-foot></table-wrap></p>
<p id="p0055">Next, we determined the expression profile of <italic>FBXW11</italic> during human development by using nonradioactive RNA <italic>in situ</italic> hybridization on human embryo sections from Carnegie Stages (CS) 15–21, obtained from the MRC/Wellcome Trust Human Developmental Biology Resource, UCL, with full ethical approval.<xref ref-type="bibr" rid="bib36"><sup>36</sup></xref> We designed two probes to target all three <italic>FBXW11</italic> human isoforms (GenBank: <ext-link ext-link-type="uri" id="intref0070" xlink:href="ncbi-n:NM_012300">NM_012300</ext-link>, <ext-link ext-link-type="uri" id="intref0075" xlink:href="ncbi-n:NM_033644">NM_033644</ext-link>, and <ext-link ext-link-type="uri" id="intref0080" xlink:href="ncbi-n:NM_033645">NM_033645</ext-link>) (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Material and Methods</xref>). Both probes showed similar expression patterns (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="supplementary-material" rid="mmc1">S3–S6</xref>).<fig id="fig3"><label>Figure 3</label><caption><p><italic>In Situ</italic> Hybridization Studies Showing <italic>FBXW11</italic> Expression During Human Eye Development</p><p>(A–E) Sagittal sections of the eye at CS15 (A), CS17 (B), CS19 (C), CS20 (D), and CS21 (E) made by using the 5′ UTR probe showing a strong <italic>FBXW11</italic> signal in the lens (A–C), the retina (A–E), the lips of the optic fissure closure (B), and regions of the developing conjunctiva (C and E). As eye development progresses, the stronger signal observed in the retina progressively shifts from the inner toward the outer retinal layers (A–D). Abbreviations are as follows: Cj = conjunctiva; HV = hyaloid vasculature; Ls = lens; OF = optic fissure; and Rn = retina.</p></caption><graphic xlink:href="gr3"></graphic></fig></p>
<p id="p0060">In the eye, <italic>FBXW11</italic> expression was seen throughout the lens at multiple time points (<xref ref-type="fig" rid="fig3">Figures 3</xref>A–3C, <xref ref-type="supplementary-material" rid="mmc1">S3</xref>A–S3F, S3I, and S3J), a fact of particular relevance to the congenitally absent and thin lenses in individual 1. In the retina, <italic>FBXW11</italic> expression appeared to shift over time from the inner to outer neuroretinal cell layers (<xref ref-type="fig" rid="fig3">Figures 3</xref>A–3D). Sagittal sections of the eye at CS17 also showed <italic>FBXW11</italic> expression at the margins of the optic fissure (<xref ref-type="fig" rid="fig3">Figures 3</xref>B, <xref ref-type="supplementary-material" rid="mmc1">S3</xref>C, and S3D), indicating a potential role in optic fissure closure, relevant to the bilateral chorioretinal colobomas in individual 1. Expression of <italic>FBXW11</italic> was also seen in the developing conjunctiva (<xref ref-type="fig" rid="fig3">Figures 3</xref>C, 3E, and <xref ref-type="supplementary-material" rid="mmc1">S3</xref>E–S3J).</p>
<p id="p0065">In the developing hand, expression of <italic>FBXW11</italic> was analyzed in parallel with expression of the chondrogenic marker <italic>SOX9</italic> (MIM: <ext-link ext-link-type="omim" id="intref0085" xlink:href="608160">608160</ext-link>).<xref ref-type="bibr" rid="bib37"><sup>37</sup></xref> At CS15, a strong signal was detected for both genes (<xref ref-type="fig" rid="fig4">Figures 4</xref>A, 4B, <xref ref-type="supplementary-material" rid="mmc1">S4</xref>A, and S4B); <italic>FBXW11</italic> displayed more widespread expression throughout the limb bud compared with the restricted expression pattern of <italic>SOX9</italic>. At CS19 and CS21, after the digits have begun to form, strong <italic>FBXW11</italic> expression was seen in the mesenchyme surrounding the developing cartilage (<xref ref-type="fig" rid="fig4">Figures 4</xref>C–4J and <xref ref-type="supplementary-material" rid="mmc1">S4</xref>C–S4J). Interestingly, digital anomalies were observed in four of the individuals we report, as well as the boy reported by Koolen et al.<xref ref-type="bibr" rid="bib8"><sup>8</sup></xref><fig id="fig4"><label>Figure 4</label><caption><p><italic>In Situ</italic> Hybridization Studies Comparing <italic>FBXW11</italic> and <italic>SOX9</italic> Expression During Human Limb Development</p><p>(A–J) Coronal sections of the forelimb at different CS stages showing the expression pattern of <italic>FBXW11</italic> (5′ UTR probe) on the left (A, C, E, G, and I) and the chondrogenic marker <italic>SOX9</italic> on the right (B, D, F, H, and J). E, F, I, and J show increased magnification of the boxed regions at CS19 (C and D) and CS21 (G and H) highlighting <italic>FBXW11</italic> expression around the developing cartilage of the digits in the hand plate.</p></caption><graphic xlink:href="gr4"></graphic></fig></p>
<p id="p0070">In the brain, <italic>FBXW11</italic> expression was present in the primitive ventricles (CS17 and CS19, <xref ref-type="fig" rid="fig5">Figures 5</xref>A–5C, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>A, S5B, <xref ref-type="supplementary-material" rid="mmc1">S6</xref>A, and S6 B), metencephalon (CS19, <xref ref-type="fig" rid="fig5">Figures 5</xref>C, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>B, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>B), hypothalamus (CS17, <xref ref-type="fig" rid="fig5">Figure 5</xref>D), and medulla (CS17, <xref ref-type="fig" rid="fig5">Figure 5</xref>E). These expression patterns are consistent with the altered brain structure, including prominence of the lateral ventricles and periventricular changes, of individuals 2, 5, 6, and 7. Furthermore, this finding supports an important role for FBXW11 in pathways, including the Hh and the Wnt cascades, essential for normal brain development.<xref ref-type="bibr" rid="bib38">38</xref>, <xref ref-type="bibr" rid="bib39">39</xref> Strong expression was also observed in the pharyngeal arches, including the mandibular process and tongue (CS17, <xref ref-type="fig" rid="fig5">Figures 5</xref>F, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>C, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>C). Expression in these structures might relate to the micrognathia or retrognathia of four of the reported individuals (1, 2, 4, and 5) and the large tongue in individual 7. Other structures showing expression included: the adrenal glands (CS17, <xref ref-type="fig" rid="fig5">Figures 5</xref>G, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>D, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>D), the lungs (CS17 and CS21, <xref ref-type="fig" rid="fig5">Figures 5</xref>G, 5H, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>E, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>E), the pulmonary artery and dorsal aorta (CS21, <xref ref-type="fig" rid="fig5">Figures 5</xref>I, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>F, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>F), the liver (CS15, <xref ref-type="fig" rid="fig5">Figures 5</xref>J, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>G, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>G), the spleen (CS15, <xref ref-type="fig" rid="fig5">Figures 5</xref>J, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>G, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>G), and the midgut (CS17, <xref ref-type="fig" rid="fig5">Figures 5</xref>K, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>H, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>H); the dorsal ganglia (CS21, <xref ref-type="fig" rid="fig5">Figures 5</xref>L, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>I, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>I) and the spinal cord (CS15, <xref ref-type="fig" rid="fig5">Figures 5</xref>J, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>G, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>G; CS17 <xref ref-type="fig" rid="fig5">Figures 5</xref>A, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>A, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>A; and CS21, <xref ref-type="fig" rid="fig5">Figures 5</xref>M, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>J, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>J), where the signal was detected in the floor plate, the roof plate, and the ventricular and intermediate layers of the spinal cord (CS21, <xref ref-type="fig" rid="fig5">Figures 5</xref>M, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>J, and <xref ref-type="supplementary-material" rid="mmc1">S6</xref>J). The expression in the pulmonary artery and dorsal aorta is interesting given the pulmonary stenosis seen in individual 5.<fig id="fig5"><label>Figure 5</label><caption><p><italic>In Situ</italic> Hybridization Studies of <italic>FBXW11</italic> in the Human Showing the Expression Pattern in Multiple Structures during Embryonic Development</p><p>Experiments performed using the 5′ UTR probe. Structures of interest are indicated by arrows.</p><p>(A) A sagittal section of embryo at CS17 (week 6), showing <italic>FBXW11</italic> expression in multiple developing structures.</p><p>(B) A sagittal section of the head at CS17 (week 6) indicating expression in the structures forming the lateral, third, and fourth ventricles.</p><p>(C) A sagittal section of the head at CS19 (week 7) showing strong expression in the regions surrounding the lateral ventricle and the metencephalon.</p><p>(D–G) Increased magnification of structures from (A) highlighting <italic>FBXW11</italic> expression in the hypothalamus (D), lower medulla (E), pharyngeal arches (F), and the adrenal glands and lungs (G).</p><p>(H) A coronal section at CS21 (week 8) showing expression in the lungs.</p><p>(I) A coronal section of the heart at CS21 showing <italic>FBXW11</italic> expression in the dorsal aorta and the pulmonary artery.</p><p>(J) A sagittal section of the embryo at CS15 (week 5) highlighting strong <italic>FBXW11</italic> expression in the liver, spleen, and spinal cord.</p><p>(K) Increased magnification of (A) showing <italic>FBXW11</italic> expression in the midgut.</p><p>(L) A transverse section at CS21 showing a strong <italic>FBXW11</italic> signal in the dorsal ganglia.</p><p>(M) A transverse section of the spinal cord at CS21 showing <italic>FBXW11</italic> expression in the floor plate, roof plate, and the ventricular and the intermediate layers of the spinal cord.</p><p>Abbreviations are as follows: AG = adrenal glands; AP = alar plate; BP = basal plate; DA = dorsal aorta; DG = dorsal ganglia; Es = Esophagus; FP = floor plate; FV = fourth ventricle; Hp = hypothalamus; IL = intermediate layer; Lg = lungs; Li = liver; LV = lateral ventricle; Md = medulla; Me = metencephalon; Mg = midgut; ML = marginal layer; MP = mandibular process; PA = pulmonary artery; Par = pharyngeal arches; RP = roof plate; SC = spinal cord; Sp = spleen; St = stomach; To = tongue; TV = third ventricle; VL = ventricular layer; and Vt = vertebra.</p></caption><graphic xlink:href="gr5"></graphic></fig></p>
<p id="p0075">The zebrafish genome includes two orthologs of <italic>FBXW11</italic>, <italic>fbxw11a</italic> and <italic>fbxw11b</italic>. These genes encode proteins with 90.4% sequence identity and 95.3% similarity. Furthermore, both zebrafish orthologs share around 85% identity and 91% similarity with human FBXW11 (GenBank: <ext-link ext-link-type="uri" id="intref0090" xlink:href="ncbi-p:NP_036432.2">NP_036432.2</ext-link>) (Fbxw11a [GenBank: <ext-link ext-link-type="uri" id="intref0095" xlink:href="ncbi-p:NP_958467.1">NP_958467.1</ext-link>]: 84.7% identity, 90.6% similarity; Fbxw11b [GenBank: <ext-link ext-link-type="uri" id="intref0100" xlink:href="ncbi-p:NP_998669.2">NP_998669.2</ext-link>]: 85.6% identity, 91.2% similarity). We performed <italic>in situ</italic> hybridization with probes designed against the low homology 3′ UTR region of <italic>fbxw11a</italic> and <italic>fbxw11b</italic> to avoid cross-detection (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Material and Methods</xref>).<xref ref-type="bibr" rid="bib40"><sup>40</sup></xref> At 4 days post fertilization (dpf), <italic>fbxw11a</italic> is expressed at low levels in the retina and brain and higher levels in the jaw mesenchyme (<xref ref-type="fig" rid="fig6">Figure 6</xref>A). <italic>fbxw11b</italic> is expressed widely in the brain and eyes, and there are high levels in the retinal ganglion layer, inner nuclear layer, in or adjacent to the outer plexiform layer, in the photoreceptor layer, ciliary marginal zone, jaw mesenchyme, oral epithelia (<xref ref-type="fig" rid="fig6">Figure 6</xref>B), and pectoral fins (<xref ref-type="supplementary-material" rid="mmc1">Figures S7</xref>A–S7D). These findings are comparable to the expression data in humans, further supporting a role for <italic>FBXW11</italic> in the development of the eye, jaw, limbs, and brain.<fig id="fig6"><label>Figure 6</label><caption><p><italic>fbxw11a</italic> and <italic>fbxw1b</italic> Are Expressed in the Zebrafish Eye, and Their Knockdown Leads to Abnormal Eye and Jaw Development</p><p>(A and B) Coronal plastic sections showing the expression pattern of <italic>fbxw11a</italic> (A) and <italic>fbxw11b</italic> (B) in 4dpf zebrafish heads detected by <italic>in situ</italic> hybridization. Dorsal is up. The scale bar in (A) is 100μm.</p><p>(C) Diagram of human FBXW11 and zebrafish Fbxw11b and Fbxw11b<sup><bold>u5010</bold></sup>. The βTrCP domain is in blue, the F-box domain is in green, the seven WD40 domains are in yellow, and the nonsense sequence of Fbxw11b<sup><bold>u5010</bold></sup> is in red. The numbers are amino acid positions in respective proteins.</p><p>(D–I) 3dpf live zebrafish <italic>MZfbxw11</italic><sup><bold><italic>u5010/u5010</italic></bold></sup> (D, E, H, and I) and <italic>MZfbxw11b</italic><sup><bold><italic>+/u5010</italic></bold></sup> (F and G) embryos injected with 500pg of control (D and E) or <italic>fbxw11a</italic> (F–I) morpholinos. Lateral (D, F, and H) and dorsal (E, G, and I) view, both anterior to left. The scale bar in (D) is 400μm and in (E) is 200μm.</p><p>(J–Q) 5dpf zebrafish <italic>MZfbxw11b</italic><sup><bold><italic>+/u5010</italic></bold></sup> (J, K, N, and P) and <italic>MZfbxw11</italic><sup><bold><italic>u5010/u5010</italic></bold></sup> (L, M, O, and Q) embryos injected with 500pg <italic>fbxw11a</italic> morpholino. (J–M) Live embryos lateral (J and L) and dorsal (K and M) view, both anterior to left. The scale bar in (J) is 400μm and in (K) is 200μm.</p><p>(N and O) Confocal imaging of DAPI-stained coronal plastic sections. The scale bar in (N) is 100μm.</p><p>(P and Q) Alcian blue staining of cartilage structures. Ventral view, anterior to left. The scale bar in (P) is 200μm.</p><p>Abbreviations are as follows: Aq = aqueous humor; bh = basihyal; ch = ceratohyal; CMZ = ciliary marginal zone; hs = hyosymplectic; INL = inner nuclear layer; IPL = inner plexiform layer; mc = Meckel’s cartilage; ONL = outer nuclear layer; OPL = outer plexiform layer; pq = palatoquadrate; PR = photoreceptor layer; and RGL, retina ganglion layer.</p></caption><graphic xlink:href="gr6"></graphic></fig></p>
<p id="p0080">To further investigate the role of <italic>FBXW11</italic> in vertebrate development, we generated zebrafish knockdown models by using a combination of morpholino and CRISPR-Cas9 technologies (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Material and Methods</xref>). Morpholino knockdown of <italic>fbxw11a</italic> resulted in no overt phenotype in zebrafish embryos (<xref ref-type="supplementary-material" rid="mmc1">Figures S7</xref>E and S7F). <italic>fbxw11b</italic> morphants consistently showed reduced eye size and a shorter and bent axis phenotype (<xref ref-type="supplementary-material" rid="mmc1">Figures S7</xref>E and S7G). Because morpholinos can have off-target effects, using CRISPR-Cas9 we induced a 7bp frameshift mutation (allele u5010, p.Asp24Leufs<sup>∗</sup>6) in <italic>fbxw11b</italic> exon 2 (<xref ref-type="fig" rid="fig6">Figures 6</xref>C and <xref ref-type="supplementary-material" rid="mmc1">S7</xref>H–S7K). <italic>fbxw11b</italic><sup><italic>u5010/u5010</italic></sup> homozygous embryos showed no abnormal phenotype and were viable and fertile. Maternal zygotic (MZ) mutant <italic>fbxw11b</italic><sup><italic>u5010/u5010</italic></sup> embryos from an <italic>fbxw11b</italic><sup><italic>u5010/u5010</italic></sup> female to <italic>fbxw11b</italic><sup><italic>+/u5010</italic></sup> male cross also showed no abnormal phenotype (<xref ref-type="fig" rid="fig6">Figures 6</xref>D and 6E).</p>
<p id="p0085">We hypothesized that compensation by <italic>fbxw11a</italic> could result in the absence of phenotype in <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup> embryos. For instance, recent studies have shown that the loss of function of a gene resulting from nonsense-mediated decay (NMD) might be compensated for by altered expression of other genes.<xref ref-type="bibr" rid="bib41">41</xref>, <xref ref-type="bibr" rid="bib42">42</xref>, <xref ref-type="bibr" rid="bib43">43</xref> Because our CRISPR-Cas9 <italic>fbxw11b</italic> mutant carries a frameshift mutation, it might be subject to NMD. Therefore, the lack of phenotype observed might be a result of compensatory gene expression, possibly by <italic>fbxw11a</italic>. However, <italic>in situ</italic> hybridization experiments did not show any obvious upregulation of <italic>fbxw11a</italic> in <italic>fbxw11b</italic> mutants at 48 h post fertilization (hpf) (not shown). Therefore, the basal level of expression of <italic>fbxw11a</italic> might be sufficient to compensate for the lack of function of <italic>fbxw11b</italic>. To begin to address this issue, we injected <italic>fbxw11a</italic> morpholino (mo<sup><italic>fbxw11a</italic></sup>) in <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup> and sibling embryos. No overt phenotype was generated before 2dpf in any genotype, and no phenotype was observed in morpholino-injected heterozygous or wild-type siblings at any stage examined. By 3dpf, <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> morphants showed abnormally developed pectoral fins and heart edema (<xref ref-type="fig" rid="fig6">Figures 6</xref>D–6I, n = 20/21); this is of interest given the digital anomalies in the individuals presented here. At 5dpf, <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> morphant knockdown embryos developed periocular edema and smaller eyes compared to <italic>MZfbxw11b</italic><sup><italic>+/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> knockdown heterozygous siblings (<xref ref-type="fig" rid="fig6">Figures 6</xref>J–6M, n = 20/20). Coronal sections showed that 5dpf <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> knockdown eyes had all the retinal layers present in the wild-type; however, the eye was smaller and misshapen. This was potentially because of a lack of aqueous humor in <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> knockdowns, although it was present in the phenotypically normal siblings at the same stage (<xref ref-type="fig" rid="fig6">Figures 6</xref>N and 6O). The reduction in eye size in mutant knockdown fish supports a role for <italic>FBXW11</italic> in eye development and supports the <italic>FBXW11</italic> variant’s being implicated in the microphthalmia observed in individual 1. Alcian blue cartilage staining in <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> knockdowns revealed abnormal development of the jaw (<xref ref-type="fig" rid="fig6">Figures 6</xref>P and 6Q). The basihyal (pharyngeal arch) cartilage structure protruded anteriorly in <italic>MZfbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> knockdowns because of shorter Meckel’s and palatoquadrate cartilages (<xref ref-type="fig" rid="fig6">Figures 6</xref>P and 6Q). These latter observations are consistent with four of our individuals presenting with retrognathia or micrognathia.</p>
<p id="p0090"><italic>FBXW11</italic> has been shown to negatively regulate the Wnt/β-catenin pathway.<xref ref-type="bibr" rid="bib44"><sup>44</sup></xref> Inhibition of Wnt/β-catenin signaling is required for the correct specification of forebrain territories, and enhanced Wnt activity leads to embryos with smaller or no eyes.<xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib46">46</xref> Enhanced Wnt activity in <italic>tcf7l1a</italic> mutants results in a smaller eye field and reduced eye size by 32hpf.<xref ref-type="bibr" rid="bib47"><sup>47</sup></xref> To determine whether Wnt/β-catenin signaling was affected in <italic>fbxw11b</italic><sup><italic>u5010/u5010</italic></sup> embryos, we assessed whether there were any genetic interactions between the mutated forms of <italic>fbxw11b</italic> and <italic>tcf7l1a</italic>. As previously shown,<xref ref-type="bibr" rid="bib47"><sup>47</sup></xref>
<italic>tcf7l1a</italic><sup><italic>−/−</italic></sup> eyes were close to 50% of the size of wild-type eyes (<xref ref-type="supplementary-material" rid="mmc1">Figure S8</xref>A). However, <italic>fbxw11b</italic>
<sup><italic>u5010/u5010</italic></sup><italic>/tcf7l1a</italic><sup><italic>−/−</italic></sup> double mutant embryos developed even smaller eyes, about 80% of the size of eyes in <italic>tcf7l1a</italic> embryos (<xref ref-type="supplementary-material" rid="mmc1">Figure S8</xref>A, p = 0.0001, <italic>tcf7l1a</italic><sup><italic>−/−</italic></sup> embryos, <inline-formula><mml:math altimg="si1.gif" id="M1"><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>˜</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> = 910.337μm<sup>3</sup> ± 118e<xref ref-type="bibr" rid="bib3"><sup>3</sup></xref> n = 20; <italic>fbxw11b</italic>
<sup><italic>u5010/u5010</italic></sup><italic>/tcf7l1a</italic><sup><italic>−/−</italic></sup> embryos, <inline-formula><mml:math altimg="si1.gif" id="M2"><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>˜</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> = 727.588 ± 145e,<xref ref-type="bibr" rid="bib3"><sup>3</sup></xref> n = 19). This suggests that abrogation of <italic>fbxw11b</italic> leads to further enhanced Wnt signaling in <italic>tcf7l1a</italic><sup><italic>−/−</italic></sup> mutants. Furthermore, exposure of embryos to a low dose of the Wnt/β-catenin agonist BIO (0.5μm treatment from 24hpf onward) led to an upward bent trunk in <italic>fbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> knockdown embryos but not in <italic>fbxw11b</italic><sup><italic>u5010/u501</italic></sup> or wild-type embryos (<xref ref-type="supplementary-material" rid="mmc1">Figures S8</xref>B–S8D, 100% n = 13, two experiments). This morphology is similar to that observed in APC mutants in which the Wnt pathway is constitutively overactivated.<xref ref-type="bibr" rid="bib48"><sup>48</sup></xref> Overall, these results suggest that the <italic>fbxw11b</italic><sup><italic>u5010/u5010</italic></sup><italic>/mo</italic><sup><italic>fbxw11a</italic></sup> knockdown embryos are sensitized to the effects of enhanced Wnt/β-catenin activity.</p>
<p id="p0095">Given the phenotype of individual 1 and our <italic>in situ</italic> and zebrafish data, we further explored whether <italic>FBXW11</italic> variants contribute more widely to developmental eye disorders by performing targeted screening in an additional 263 individuals with anophthalmia, microphthalmia, or coloboma (AMC) by using high-resolution melt curve analysis<xref ref-type="bibr" rid="bib49"><sup>49</sup></xref> or Sanger sequencing (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Material and Methods</xref>). Excluding three 3′ UTR private variants (c.<sup>∗</sup>4064_<sup>∗</sup>4065insT [chr5:171,288,698–171,288,699], c.<sup>∗</sup>2867G&gt;A [chr5:171,289,855], c.<sup>∗</sup>2592C&gt;T [chr5:171,290,168]; GenBank: <ext-link ext-link-type="uri" id="intref0105" xlink:href="ncbi-n:NM_012300.2">NM_012300.2</ext-link>, GRCh37/hg19) inherited from unaffected parents, no functionally relevant variants were identified. Similarly, array comparative genome hybridization (aCGH) analysis of 77 individuals, including individual 1, with isolated or syndromic AMC did not identify any copy number aberrations affecting <italic>FBXW11</italic>. This indicates variants in <italic>FBXW11</italic> might only rarely be associated with human AMC.</p>
<p id="p0100">FBXW11 is involved in multiple developmental pathways, including Wnt signaling, which plays a crucial role in the regulation of cell proliferation, tissue patterning, and organ morphogenesis. Wnt signaling can be divided into canonical and non-canonical pathways; and a key element of the former is ubiquitination of β-catenin (<xref ref-type="supplementary-material" rid="mmc1">Figures S9</xref>A and S9B).<xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib50">50</xref> This ubiquitination, controlled by the SCF complex, is directed either by BTRC or its paralog BTRC2, encoded by <italic>BTRC</italic> and <italic>FBXW11</italic>, respectively.<xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib51">51</xref> Aberrations of this pathway can lead to a range of human pathologies, including developmental disorders affecting the limbs, as well as neurodevelopmental and psychiatric disorders.<xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib52">52</xref>, <xref ref-type="bibr" rid="bib53">53</xref> There is also significant evidence of the importance of Wnt signaling in developmental eye disorders in mouse models.<xref ref-type="bibr" rid="bib54">54</xref>, <xref ref-type="bibr" rid="bib55">55</xref></p>
<p id="p0105"><italic>FBXW11</italic> is also involved in Hh signaling by regulating the ubiquitination of GLI transcription factors (<xref ref-type="supplementary-material" rid="mmc1">Figures S9</xref>C and S9D). Variants in Hh pathway genes are associated with developmental anomalies, some of which are comparable to those observed in the individuals presented here. Copy number gains encompassing <italic>BTRC</italic> are linked with developmental limb anomalies.<xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib56">56</xref>
<italic>Drosophila</italic> with mutations in <italic>Slimb,</italic> the ortholog of both <italic>FBXW11</italic> and <italic>BTRC</italic>, develop supernumerary limbs or ectopic legs and eye anomalies.<xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib58">58</xref>, <xref ref-type="bibr" rid="bib59">59</xref> In mice, mutations of GLI transcription factors can cause multiple malformations, including polydactyly, anophthalmia, and coloboma.<xref ref-type="bibr" rid="bib60">60</xref>, <xref ref-type="bibr" rid="bib61">61</xref>, <xref ref-type="bibr" rid="bib62">62</xref>, <xref ref-type="bibr" rid="bib63">63</xref> Finally, in humans, genetic variants affecting members of the Hh signaling pathway, such as <italic>SHH</italic> and <italic>PTCH1</italic> (MIM: <ext-link ext-link-type="omim" id="intref0110" xlink:href="601309">601309</ext-link>), have been associated with developmental eye anomalies and HPE.<xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib65">65</xref>, <xref ref-type="bibr" rid="bib66">66</xref>
<italic>GLI2</italic> (MIM: <ext-link ext-link-type="omim" id="intref0115" xlink:href="165230">165230</ext-link>) and <italic>GLI3</italic> (MIM: <ext-link ext-link-type="omim" id="intref0120" xlink:href="165240">165240</ext-link>) variants have also been reported in individuals with a variety of phenotypic features including HPE, polydactyly, and anophthalmia.<xref ref-type="bibr" rid="bib67">67</xref>, <xref ref-type="bibr" rid="bib68">68</xref>, <xref ref-type="bibr" rid="bib69">69</xref>, <xref ref-type="bibr" rid="bib70">70</xref> However, some of the <italic>GLI2</italic> variants have subsequently been classified as benign in ClinVar.</p>
<p id="p0110">Individual 7 presented with distinctive characteristics of Noonan syndrome, a phenotype linked to RAS-MAPK signaling dysregulation.<xref ref-type="bibr" rid="bib71">71</xref>, <xref ref-type="bibr" rid="bib72">72</xref> Ras trafficking and activity are regulated by several mechanisms, including ubiquitination, which can be mediated by different ubiquitin ligase complexes.<xref ref-type="bibr" rid="bib73"><sup>73</sup></xref> Recent studies have also identified a circuit involving LZTR1, a Kelch-domain-containing protein altered in Noonan syndrome. LZRT1 functions as a substrate receptor in the cullin 3 ubiquitin ligase complex involved in the ubiquitination and functional down modulation of HRAS.<xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib74">74</xref>, <xref ref-type="bibr" rid="bib75">75</xref> Interestingly, the SCF-β-TrCP E3 ligase complex has also been implicated in the ubiquitination and proteasomal degradation of HRAS,<xref ref-type="bibr" rid="bib76"><sup>76</sup></xref> supporting an unanticipated functional link between FBXW11 and RAS signaling modulation warranting further exploration.</p>
<p id="p0115">Our structural analyses provide evidence of the specific impact of the identified variants on FBXW11 function, as well as for the dominant role of these amino acid changes. Specifically, the variants are predicted to impair proper recognition and/or binding of substrates by the SCF ubiquitin ligase complex. In contrast to the presently reported variants, the two <italic>de novo</italic> changes previously reported in the ASD-affected individuals are predicted to alter protein function by different mechanisms. The exon 3 missense variant is located within the homodimerization domain and might interfere with protein dimerization. Instead, the nonsense substitution affecting exon 4 is predicted to lead to NMD or a truncated protein, potentially reducing the amount of functional protein. Although several of our individuals presented with features of ASD, little clinical information is available for the individuals from these ASD studies, except that the individual carrying the nonsense variant has a high IQ.<xref ref-type="bibr" rid="bib28"><sup>28</sup></xref> This limits our ability to suggest further how these alternate mechanisms might contribute to phenotypic variation.</p>
<p id="p0120">In conclusion, we report seven unrelated individuals presenting with phenotypes including eye, digital, and jaw anomalies, and neurodevelopmental or psychiatric disorders. These individuals all carry <italic>de novo</italic> probably pathogenic missense variants in <italic>FBXW11</italic>, a member of the ubiquitin ligase SCF complex that functions as a regulator of both the Wnt and Hh signaling developmental pathways. <italic>In silico</italic> analyses provide a model for the functional impact of the variants; <italic>in vitro</italic> experiments with human and zebrafish developmental tissue supported early expression of <italic>FBXW11</italic> in relevant structures and <italic>in vivo</italic> zebrafish studies documented the relevance of FBXW11 in developmental processes affected in this phenotypic series. Collectively, these data support the role of <italic>FBXW11</italic> variants in human developmental disorders affecting the brain, eye, jaw, and digits, possibly via modulation of the Wnt/β-catenin, Hh, and RAS signaling pathways.</p>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Philippakis</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Azzariti</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Beltran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brookes</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Brownstein</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Brudno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Buske</surname>
<given-names>O.J.</given-names>
</name>
<name>
<surname>Carey</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Doll</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The Matchmaker Exchange: A platform for rare disease gene discovery</article-title>
<source/>Hum. Mutat.
          <volume>36</volume>
<year>2015</year>
<fpage>915</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="pmid">26295439</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobreira</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schiettecatte</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hamosh</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>GeneMatcher: A matching tool for connecting investigators with an interest in the same gene</article-title>
<source/>Hum. Mutat.
          <volume>36</volume>
<year>2015</year>
<fpage>928</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">26220891</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritzen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kuechler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grimmel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sturm</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hundertmark</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kreiß</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Strom</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies</article-title>
<source/>Hum. Genet.
          <volume>137</volume>
<year>2018</year>
<fpage>401</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="pmid">29796876</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sadleir</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>Asadollahi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Azzarello-Burri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ousager</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Boonsawat</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bruel</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Buchert</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Calpena</surname>
<given-names>E.</given-names>
</name>
<collab>University of Washington Center for Mendelian Genomics</collab>
<collab>DDD Study</collab>
</person-group>
<article-title>De novo variants in the F-box protein FBXO11 in 20 individuals with a variable neurodevelopmental disorder</article-title>
<source/>Am. J. Hum. Genet.
          <volume>103</volume>
<year>2018</year>
<fpage>305</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="pmid">30057029</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jansen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van der Werf</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Innes</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Afenjar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Atwal</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>van Binsbergen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>van den Boogaard</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Castiglia</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms</article-title>
<source/>Eur. J. Hum. Genet.
          <volume>27</volume>
<year>2019</year>
<fpage>738</fpage>
<lpage>746</lpage>
<pub-id pub-id-type="pmid">30679813</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krumbach</surname>
<given-names>O.H.F.</given-names>
</name>
<name>
<surname>Pantaleoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pannone</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Farina</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dvorsky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lepri</surname>
<given-names>F.</given-names>
</name>
<collab>University of Washington Center for Mendelian Genomics</collab>
</person-group>
<article-title>Functional dysregulation of CDC42 causes diverse developmental phenotypes</article-title>
<source/>Am. J. Hum. Genet.
          <volume>102</volume>
<year>2018</year>
<fpage>309</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="pmid">29394990</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reijnders</surname>
<given-names>M.R.F.</given-names>
</name>
<name>
<surname>Ansor</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Kousi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Clarkson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Clayton-Smith</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Corning</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>W.W.K.</given-names>
</name>
<collab>Deciphering Developmental Disorders Study</collab>
</person-group>
<article-title>RAC1 missense mutations in developmental disorders with diverse phenotypes</article-title>
<source/>Am. J. Hum. Genet.
          <volume>101</volume>
<year>2017</year>
<fpage>466</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="pmid">28886345</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koolen</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Herbergs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Bokhoven</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stroink</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sistermans</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Geurts van Kessel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>B.B.</given-names>
</name>
</person-group>
<article-title>Holoprosencephaly and preaxial polydactyly associated with a 1.24 Mb duplication encompassing FBXW11 at 5q35.1</article-title>
<source/>J. Hum. Genet.
          <volume>51</volume>
<year>2006</year>
<fpage>721</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="pmid">16865294</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Angione</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Milunsky</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Identification of critical region responsible for split hand/foot malformation type 3 (SHFM3) phenotype through systematic review of literature and mapping of breakpoints using microarray data</article-title>
<source/>Microarrays (Basel)
          <volume>5</volume>
<year>2015</year>
<fpage>E2</fpage>
<pub-id pub-id-type="pmid">27600068</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nusse</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Clevers</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</article-title>
<source/>Cell
          <volume>169</volume>
<year>2017</year>
<fpage>985</fpage>
<lpage>999</lpage>
<pub-id pub-id-type="pmid">28575679</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchs</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Z.Q.</given-names>
</name>
<name>
<surname>Ronai</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin</article-title>
<source/>Oncogene
          <volume>18</volume>
<year>1999</year>
<fpage>2039</fpage>
<lpage>2046</lpage>
<pub-id pub-id-type="pmid">10321728</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujimura</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>WNT/β-catenin signaling in vertebrate eye development</article-title>
<source/>Front. Cell Dev. Biol.
          <volume>4</volume>
<year>2016</year>
<fpage>138</fpage>
<pub-id pub-id-type="pmid">27965955</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noelanders</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vleminckx</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>How Wnt signaling builds the brain: Bridging development and disease</article-title>
<source/>Neuroscientist
          <volume>23</volume>
<year>2017</year>
<fpage>314</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="pmid">27624848</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raspopovic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marcon</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sharpe</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Modeling digits. Digit patterning is controlled by a Bmp-Sox9-Wnt Turing network modulated by morphogen gradients</article-title>
<source/>Science
          <volume>345</volume>
<year>2014</year>
<fpage>566</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="pmid">25082703</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavodeassi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Creuzet</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Etchevers</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>The hedgehog pathway and ocular developmental anomalies</article-title>
<source/>Hum. Genet.
          <year>2018</year>
<comment>Epub ahead of print</comment>
</element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Qattan</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Zone of polarizing activity regulatory sequence mutations/duplications with preaxial polydactyly and longitudinal preaxial ray deficiency in the phenotype: A review of human cases, animal models, and insights regarding the pathogenesis</article-title>
<source/>BioMed Res. Int.
          <volume>2018</volume>
<year>2018</year>
<fpage>1573871</fpage>
<pub-id pub-id-type="pmid">29651423</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fantes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ragge</surname>
<given-names>N.K.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>McGill</surname>
<given-names>N.I.</given-names>
</name>
<name>
<surname>Collin</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Howard-Peebles</surname>
<given-names>P.N.</given-names>
</name>
<name>
<surname>Hayward</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vivian</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>FitzPatrick</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Mutations in SOX2 cause anophthalmia</article-title>
<source/>Nat. Genet.
          <volume>33</volume>
<year>2003</year>
<fpage>461</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="pmid">12612584</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Errichiello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gorgone</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Giuliano</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Iadarola</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cosentino</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rossato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kurtas</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Delledonne</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mattina</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zuffardi</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>SOX2: Not always eye malformations. Severe genital but no major ocular anomalies in a female patient with the recurrent c.70del20 variant</article-title>
<source/>Eur. J. Med. Genet.
          <volume>61</volume>
<year>2018</year>
<fpage>335</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="pmid">29371155</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cardozo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lovering</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Elledge</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Pagano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Systematic analysis and nomenclature of mammalian F-box proteins</article-title>
<source/>Genes Dev.
          <volume>18</volume>
<year>2004</year>
<fpage>2573</fpage>
<lpage>2580</lpage>
<pub-id pub-id-type="pmid">15520277</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schulman</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Jeffrey</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Pavletich</surname>
<given-names>N.P.</given-names>
</name>
</person-group>
<article-title>Structure of a beta-TrCP1-Skp1-beta-catenin complex: Destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase</article-title>
<source/>Mol. Cell
          <volume>11</volume>
<year>2003</year>
<fpage>1445</fpage>
<lpage>1456</lpage>
<pub-id pub-id-type="pmid">12820959</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Structure and function of WD40 domain proteins</article-title>
<source/>Protein Cell
          <volume>2</volume>
<year>2011</year>
<fpage>202</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">21468892</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Hattab</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Almannai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Faqeih</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Al Asmari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saleh</surname>
<given-names>M.A.M.</given-names>
</name>
<name>
<surname>Elamin</surname>
<given-names>M.A.O.</given-names>
</name>
<name>
<surname>Alfadhel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alkuraya</surname>
<given-names>F.S.</given-names>
</name>
</person-group>
<article-title>Molecular and clinical spectra of FBXL4 deficiency</article-title>
<source/>Hum. Mutat.
          <volume>38</volume>
<year>2017</year>
<fpage>1649</fpage>
<lpage>1659</lpage>
<pub-id pub-id-type="pmid">28940506</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willems</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Schwab</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tyers</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A hitchhiker’s guide to the cullin ubiquitin ligases: SCF and its kin</article-title>
<source/>Biochim. Biophys. Acta
          <volume>1695</volume>
<year>2004</year>
<fpage>133</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">15571813</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrovski</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Heinzen</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>D.B.</given-names>
</name>
</person-group>
<article-title>Genic intolerance to functional variation and the interpretation of personal genomes</article-title>
<source/>PLoS Genet.
          <volume>9</volume>
<year>2013</year>
<fpage>e1003709</fpage>
<pub-id pub-id-type="pmid">23990802</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samocha</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sabo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Kosmicki</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Rehnström</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mallick</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A framework for the interpretation of de novo mutation in human disease</article-title>
<source/>Nat. Genet.
          <volume>46</volume>
<year>2014</year>
<fpage>944</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="pmid">25086666</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Karczewski</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Minikel</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>O’Donnell-Luria</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>B.B.</given-names>
</name>
<collab>Exome Aggregation Consortium</collab>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <volume>536</volume>
<year>2016</year>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Poultney</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cicek</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fromer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S.</given-names>
</name>
<collab>DDD Study</collab>
<collab>Homozygosity Mapping Collaborative for Autism</collab>
<collab>UK10K Consortium</collab>
</person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
<source/>Nature
          <volume>515</volume>
<year>2014</year>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stessman</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>K.E.</given-names>
</name>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature
          <volume>515</volume>
<year>2014</year>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Asimenos</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Batzoglou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sidow</surname>
<given-names>A.</given-names>
</name>
<collab>NISC Comparative Sequencing Program</collab>
</person-group>
<article-title>Distribution and intensity of constraint in mammalian genomic sequence</article-title>
<source/>Genome Res.
          <volume>15</volume>
<year>2005</year>
<fpage>901</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="pmid">15965027</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davydov</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Goode</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Sirota</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Sidow</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Batzoglou</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Identifying a high fraction of the human genome to be under selective constraint using GERP++</article-title>
<source/>PLoS Comput. Biol.
          <volume>6</volume>
<year>2010</year>
<fpage>e1001025</fpage>
<pub-id pub-id-type="pmid">21152010</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Havrilla</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Layer</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>A map of constrained coding regions in the human genome</article-title>
<source/>Nat. Genet.
          <volume>51</volume>
<year>2019</year>
<fpage>88</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">30531870</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gilliland</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Weissig</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shindyalov</surname>
<given-names>I.N.</given-names>
</name>
<name>
<surname>Bourne</surname>
<given-names>P.E.</given-names>
</name>
</person-group>
<article-title>The Protein Data Bank</article-title>
<source/>Nucleic Acids Res.
          <volume>28</volume>
<year>2000</year>
<fpage>235</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">10592235</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fidan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bellacchio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pantaleoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schneider-Heieck</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Borck</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Salviati</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zenker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cirstea</surname>
<given-names>I.C.</given-names>
</name>
</person-group>
<article-title>Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the kelch domain substrate-recognition surface and enhance RAS-MAPK signaling</article-title>
<source/>Hum. Mol. Genet
          <volume>28</volume>
<year>2019</year>
<fpage>1007</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="pmid">30481304</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lelieveld</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Wiel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Venselaar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vriend</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>L.E.L.M.</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Spatial clustering of de novo missense mutations identifies candidate neurodevelopmental disorder-associated genes</article-title>
<source/>Am. J. Hum. Genet.
          <volume>101</volume>
<year>2017</year>
<fpage>478</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="pmid">28867141</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schymkowitz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Borg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stricher</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nys</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The FoldX web server: An online force field</article-title>
<source/>Nucleic Acids Res.
          <volume>33</volume>
<year>2005</year>
<comment>W382-8</comment>
</element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Gerrelli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Copp</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>FOXP2 expression during brain development coincides with adult sites of pathology in a severe speech and language disorder</article-title>
<source/>Brain
          <volume>126</volume>
<year>2003</year>
<fpage>2455</fpage>
<lpage>2462</lpage>
<pub-id pub-id-type="pmid">12876151</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morais da Silva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hacker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Goodfellow</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Swain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lovell-Badge</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds</article-title>
<source/>Nat. Genet.
          <volume>14</volume>
<year>1996</year>
<fpage>62</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">8782821</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hooper</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Communicating with Hedgehogs</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <volume>6</volume>
<year>2005</year>
<fpage>306</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">15803137</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldinger</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Mendelsohn</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cohn</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Alkuraya</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Dobyns</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Curry</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Variable brain phenotype primarily affects the brainstem and cerebellum in patients with osteogenesis imperfecta caused by recessive WNT1 mutations</article-title>
<source/>J. Med. Genet.
          <volume>53</volume>
<year>2016</year>
<fpage>427</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="pmid">26671912</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thisse</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thisse</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title>
<source/>Nat. Protoc.
          <volume>3</volume>
<year>2008</year>
<fpage>59</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">18193022</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Brolosy</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Kontarakis</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kuenne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Günther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kikhi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Boezio</surname>
<given-names>G.L.M.</given-names>
</name>
<name>
<surname>Takacs</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Genetic compensation triggered by mutant mRNA degradation</article-title>
<source/>Nature
          <volume>568</volume>
<year>2019</year>
<fpage>193</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="pmid">30944477</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Brolosy</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Stainier</surname>
<given-names>D.Y.R.</given-names>
</name>
</person-group>
<article-title>Genetic compensation: A phenomenon in search of mechanisms</article-title>
<source/>PLoS Genet.
          <volume>13</volume>
<year>2017</year>
<fpage>e1006780</fpage>
<pub-id pub-id-type="pmid">28704371</pub-id>
</element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation id="sref43" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kontarakis</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gerri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nolte</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hölper</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krüger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stainier</surname>
<given-names>D.Y.</given-names>
</name>
</person-group>
<article-title>Genetic compensation induced by deleterious mutations but not gene knockdowns</article-title>
<source/>Nature
          <volume>524</volume>
<year>2015</year>
<fpage>230</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="pmid">26168398</pub-id>
</element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aberle</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stappert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kispert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kemler</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>beta-catenin is a target for the ubiquitin-proteasome pathway</article-title>
<source/>EMBO J.
          <volume>16</volume>
<year>1997</year>
<fpage>3797</fpage>
<lpage>3804</lpage>
<pub-id pub-id-type="pmid">9233789</pub-id>
</element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Artinger</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Chandrasekharappa</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Driever</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chitnis</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>Repressor activity of Headless/Tcf3 is essential for vertebrate head formation</article-title>
<source/>Nature
          <volume>407</volume>
<year>2000</year>
<fpage>913</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="pmid">11057671</pub-id>
</element-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation id="sref46" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heisenberg</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Houart</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Take-Uchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Coutinho</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Masai</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Caneparo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Concha</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Geisler</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A mutation in the Gsk3-binding domain of zebrafish Masterblind/Axin1 leads to a fate transformation of telencephalon and eyes to diencephalon</article-title>
<source/>Genes Dev.
          <volume>15</volume>
<year>2001</year>
<fpage>1427</fpage>
<lpage>1434</lpage>
<pub-id pub-id-type="pmid">11390362</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Cavodeassi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stickney</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Wierzbicki</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>B.Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ambrosio</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Compensatory growth renders Tcf7l1a dispensable for eye formation despite its requirement in eye field specification</article-title>
<source/>eLife
          <volume>8</volume>
<year>2019</year>
<fpage>e40093</fpage>
<pub-id pub-id-type="pmid">30777146</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hurlstone</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Haramis</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Wienholds</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Begthel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Korving</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Van Eeden</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cuppen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zivkovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Plasterk</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Clevers</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The Wnt/beta-catenin pathway regulates cardiac valve formation</article-title>
<source/>Nature
          <volume>425</volume>
<year>2003</year>
<fpage>633</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="pmid">14534590</pub-id>
</element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation id="sref49" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennerson</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Warburton</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nelis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brewer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Polly</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>De Jonghe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Timmerman</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease</article-title>
<source/>Clin. Chem.
          <volume>53</volume>
<year>2007</year>
<fpage>349</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">17200131</pub-id>
</element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation id="sref50" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stamos</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Weis</surname>
<given-names>W.I.</given-names>
</name>
</person-group>
<article-title>The β-catenin destruction complex</article-title>
<source/>Cold Spring Harb. Perspect. Biol.
          <volume>5</volume>
<year>2013</year>
<fpage>a007898</fpage>
<pub-id pub-id-type="pmid">23169527</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winston</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Strack</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Beer-Romero</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Elledge</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro</article-title>
<source/>Genes Dev.
          <volume>13</volume>
<year>1999</year>
<fpage>270</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="pmid">9990852</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pawlik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Elcioglu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Aglan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kayserili</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yigit</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Percin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nürnberg</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cenani</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <volume>86</volume>
<year>2010</year>
<fpage>696</fpage>
<lpage>706</lpage>
<pub-id pub-id-type="pmid">20381006</pub-id>
</element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoseth</surname>
<given-names>E.Z.</given-names>
</name>
<name>
<surname>Krull</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dieset</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mørch</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Hope</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gardsjord</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Steen</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Melle</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brattbakk</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Steen</surname>
<given-names>V.M.</given-names>
</name>
</person-group>
<article-title>Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder</article-title>
<source/>Transl. Psychiatry
          <volume>8</volume>
<year>2018</year>
<fpage>55</fpage>
<pub-id pub-id-type="pmid">29507296</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation id="sref54" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wijesinghe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Abud</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Taketo</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>de Iongh</surname>
<given-names>R.U.</given-names>
</name>
</person-group>
<article-title>Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation</article-title>
<source/>Invest. Ophthalmol. Vis. Sci.
          <volume>50</volume>
<year>2009</year>
<fpage>4794</fpage>
<lpage>4806</lpage>
<pub-id pub-id-type="pmid">19515997</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alldredge</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fuhrmann</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Loss of Axin2 causes ocular defects during mouse eye development</article-title>
<source/>Invest. Ophthalmol. Vis. Sci.
          <volume>57</volume>
<year>2016</year>
<fpage>5253</fpage>
<lpage>5262</lpage>
<pub-id pub-id-type="pmid">27701636</pub-id>
</element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Sicko</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Browne</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Romitti</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Edmunds</surname>
<given-names>Z.L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Druschel</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Caggana</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Copy-number variants and candidate gene mutations in isolated split hand/foot malformation</article-title>
<source/>J. Hum. Genet.
          <volume>62</volume>
<year>2017</year>
<fpage>877</fpage>
<lpage>884</lpage>
<pub-id pub-id-type="pmid">28539665</pub-id>
</element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation id="sref57" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Struhl</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb</article-title>
<source/>Nature
          <volume>391</volume>
<year>1998</year>
<fpage>493</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="pmid">9461217</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milétich</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Limbourg-Bouchon</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Drosophila null slimb clones transiently deregulate Hedgehog-independent transcription of wingless in all limb discs, and induce decapentaplegic transcription linked to imaginal disc regeneration</article-title>
<source/>Mech. Dev.
          <volume>93</volume>
<year>2000</year>
<fpage>15</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmid">10781936</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skwarek</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Windler</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>de Vreede</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Bilder</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The F-box protein Slmb restricts the activity of aPKC to polarize epithelial cells</article-title>
<source/>Development
          <volume>141</volume>
<year>2014</year>
<fpage>2978</fpage>
<lpage>2983</lpage>
<pub-id pub-id-type="pmid">25053431</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Extra-toes: A new mutant gene causing multiple abnormalities in the mouse</article-title>
<source/>J. Embryol. Exp. Morphol.
          <volume>17</volume>
<year>1967</year>
<fpage>543</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="pmid">6049666</pub-id>
</element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Besecke</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The development of the eye in homozygotes of the mouse mutant Extra-toes</article-title>
<source/>Anat. Embryol. (Berl.)
          <volume>184</volume>
<year>1991</year>
<fpage>355</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="pmid">1952108</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furimsky</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>V.A.</given-names>
</name>
</person-group>
<article-title>Complementary Gli activity mediates early patterning of the mouse visual system</article-title>
<source/>Dev. Dyn.
          <volume>235</volume>
<year>2006</year>
<fpage>594</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="pmid">16342201</pub-id>
</element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hui</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Joyner</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>A mouse model of greig cephalopolysyndactyly syndrome: The extra-toesJ mutation contains an intragenic deletion of the Gli3 gene</article-title>
<source/>Nat. Genet.
          <volume>3</volume>
<year>1993</year>
<fpage>241</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">8387379</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakrania</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Efthymiou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Salt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bunyan</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Wyatt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ponting</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lindley</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Mutations in BMP4 cause eye, brain, and digit developmental anomalies: Overlap between the BMP4 and hedgehog signaling pathways</article-title>
<source/>Am. J. Hum. Genet.
          <volume>82</volume>
<year>2008</year>
<fpage>304</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="pmid">18252212</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<label>65</label>
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakrania</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ugur Iseri</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Wyatt</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Bunyan</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Salt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ramsay</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>D.O.</given-names>
</name>
<name>
<surname>Ragge</surname>
<given-names>N.K.</given-names>
</name>
</person-group>
<article-title>Sonic hedgehog mutations are an uncommon cause of developmental eye anomalies</article-title>
<source/>Am. J. Med. Genet. A.
          <volume>152A</volume>
<year>2010</year>
<fpage>1310</fpage>
<lpage>1313</lpage>
<pub-id pub-id-type="pmid">20425842</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<label>66</label>
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chassaing</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>McKnight</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Niederriter</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Causse</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Desmaison</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lamarre</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vincent-Delorme</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pasquier</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Targeted resequencing identifies PTCH1 as a major contributor to ocular developmental anomalies and extends the SOX2 regulatory network</article-title>
<source/>Genome Res.
          <volume>26</volume>
<year>2016</year>
<fpage>474</fpage>
<lpage>485</lpage>
<pub-id pub-id-type="pmid">26893459</pub-id>
</element-citation>
</ref>
<ref id="bib67">
<label>67</label>
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roessler</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.Z.</given-names>
</name>
<name>
<surname>Mullor</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Casas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>W.P.</given-names>
</name>
<name>
<surname>Gillessen-Kaesbach</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Ruiz i Altaba</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muenke</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <volume>100</volume>
<year>2003</year>
<fpage>13424</fpage>
<lpage>13429</lpage>
<pub-id pub-id-type="pmid">14581620</pub-id>
</element-citation>
</ref>
<ref id="bib68">
<label>68</label>
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahimov</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>de Miranda</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Richieri-Costa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>GLI2 mutations in four Brazilian patients: How wide is the phenotypic spectrum?</article-title>
<source/>Am. J. Med. Genet. A.
          <volume>140</volume>
<year>2006</year>
<fpage>2571</fpage>
<lpage>2576</lpage>
<pub-id pub-id-type="pmid">17096318</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<label>69</label>
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Sapp</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Amor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Aftimos</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aleck</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Bocian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bodurtha</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Curry</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations</article-title>
<source/>Hum. Mutat.
          <volume>31</volume>
<year>2010</year>
<fpage>1142</fpage>
<lpage>1154</lpage>
<pub-id pub-id-type="pmid">20672375</pub-id>
</element-citation>
</ref>
<ref id="bib70">
<label>70</label>
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertolacini</surname>
<given-names>C.D.P.</given-names>
</name>
<name>
<surname>Ribeiro-Bicudo</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Petrin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Richieri-Costa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Clinical findings in patients with GLI2 mutations--phenotypic variability</article-title>
<source/>Clin. Genet.
          <volume>81</volume>
<year>2012</year>
<fpage>70</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">21204792</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<label>71</label>
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Allanson</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gelb</surname>
<given-names>B.D.</given-names>
</name>
</person-group>
<article-title>Noonan syndrome</article-title>
<source/>Lancet
          <volume>381</volume>
<year>2013</year>
<fpage>333</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">23312968</pub-id>
</element-citation>
</ref>
<ref id="bib72">
<label>72</label>
<element-citation id="sref72" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tartaglia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gelb</surname>
<given-names>B.D.</given-names>
</name>
</person-group>
<article-title>Disorders of dysregulated signal traffic through the RAS-MAPK pathway: Phenotypic spectrum and molecular mechanisms</article-title>
<source/>Ann. N Y Acad. Sci.
          <volume>1214</volume>
<year>2010</year>
<fpage>99</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="pmid">20958325</pub-id>
</element-citation>
</ref>
<ref id="bib73">
<label>73</label>
<element-citation id="sref73" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de la Vega</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Burrows</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Ubiquitination: Added complexity in Ras and Rho family GTPase function</article-title>
<source/>Small GTPases
          <volume>2</volume>
<year>2011</year>
<fpage>192</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="pmid">22145091</pub-id>
</element-citation>
</ref>
<ref id="bib74">
<label>74</label>
<element-citation id="sref74" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steklov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baietti</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Batiuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carai</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Najm</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Renzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination</article-title>
<source/>Science
          <volume>362</volume>
<year>2018</year>
<fpage>1177</fpage>
<lpage>1182</lpage>
<pub-id pub-id-type="pmid">30442762</pub-id>
</element-citation>
</ref>
<ref id="bib75">
<label>75</label>
<element-citation id="sref75" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bigenzahn</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Collu</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Kartnig</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pieraks</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vladimer</surname>
<given-names>G.I.</given-names>
</name>
<name>
<surname>Heinz</surname>
<given-names>L.X.</given-names>
</name>
<name>
<surname>Sedlyarov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Schischlik</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fauster</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rebsamen</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>LZTR1 is a regulator of RAS ubiquitination and signaling</article-title>
<source/>Science
          <volume>362</volume>
<year>2018</year>
<fpage>1171</fpage>
<lpage>1177</lpage>
<pub-id pub-id-type="pmid">30442766</pub-id>
</element-citation>
</ref>
<ref id="bib76">
<label>76</label>
<element-citation id="sref76" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>K.Y.</given-names>
</name>
</person-group>
<article-title>H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation</article-title>
<source/>J. Cell Sci.
          <volume>122</volume>
<year>2009</year>
<fpage>842</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="pmid">19240121</pub-id>
</element-citation>
</ref>
<ref id="bib77">
<label>77</label>
<element-citation id="sref77" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>InterVar: Clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines</article-title>
<source/>Am. J. Hum. Genet.
          <volume>100</volume>
<year>2017</year>
<fpage>267</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="pmid">28132688</pub-id>
</element-citation>
</ref>
<ref id="bib78">
<label>78</label>
<element-citation id="sref78" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>
<source/>Nucleic Acids Res.
          <volume>31</volume>
<year>2003</year>
<fpage>3812</fpage>
<lpage>3814</lpage>
<pub-id pub-id-type="pmid">12824425</pub-id>
</element-citation>
</ref>
<ref id="bib79">
<label>79</label>
<element-citation id="sref79" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peshkin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ramensky</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>Gerasimova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kondrashov</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>A method and server for predicting damaging missense mutations</article-title>
<source/>Nat. Methods
          <volume>7</volume>
<year>2010</year>
<fpage>248</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="pmid">20354512</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="app3">
<title>Web Resources</title>
<p id="p0145">
<list id="ulist0010" list-type="simple">
<list-item id="u0010">
<p id="p0150">Allen Brain Atlas, <ext-link ext-link-type="uri" id="intref0145" xlink:href="https://www.brain-map.org/">https://www.brain-map.org/</ext-link></p>
</list-item>
<list-item id="u0015">
<p id="p0155">ANNOVAR, <ext-link ext-link-type="uri" id="intref0150" xlink:href="http://annovar.openbioinformatics.org/">http://annovar.openbioinformatics.org/</ext-link></p>
</list-item>
<list-item id="u0020">
<p id="p0160">CCR Browser, <ext-link ext-link-type="uri" id="intref0155" xlink:href="https://s3.us-east-2.amazonaws.com/ccrs/ccr.html">https://s3.us-east-2.amazonaws.com/ccrs/ccr.html</ext-link></p>
</list-item>
<list-item id="u0025">
<p id="p0165">ClinVar, <ext-link ext-link-type="uri" id="intref0160" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link></p>
</list-item>
<list-item id="u0030">
<p id="p0170">EMBOSS Needle, <ext-link ext-link-type="uri" id="intref0165" xlink:href="https://www.ebi.ac.uk/Tools/psa/emboss_needle/">https://www.ebi.ac.uk/Tools/psa/emboss_needle/</ext-link></p>
</list-item>
<list-item id="u0035">
<p id="p0175">ExAC, <ext-link ext-link-type="uri" id="intref0170" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link></p>
</list-item>
<list-item id="u0040">
<p id="p0180">GeneMatcher, <ext-link ext-link-type="uri" id="intref0175" xlink:href="https://genematcher.org/">https://genematcher.org/</ext-link></p>
</list-item>
<list-item id="u0045">
<p id="p0185">gnomAD, <ext-link ext-link-type="uri" id="intref0180" xlink:href="https://gnomad.broadinstitute.org/">https://gnomad.broadinstitute.org/</ext-link></p>
</list-item>
<list-item id="u0050">
<p id="p0190">InterVar, <ext-link ext-link-type="uri" id="intref0185" xlink:href="http://wintervar.wglab.org/">http://wintervar.wglab.org/</ext-link></p>
</list-item>
<list-item id="u0055">
<p id="p0195">OMIM, <ext-link ext-link-type="uri" id="intref0190" xlink:href="https://www.omim.org/">https://www.omim.org/</ext-link></p>
</list-item>
<list-item id="u0060">
<p id="p0200">Picard, <ext-link ext-link-type="uri" id="intref0195" xlink:href="http://broadinstitute.github.io/picard/index.html">http://broadinstitute.github.io/picard/index.html</ext-link></p>
</list-item>
<list-item id="u0065">
<p id="p0205">POVRay, <ext-link ext-link-type="uri" id="intref0200" xlink:href="http://www.povray.org/">www.povray.org/</ext-link></p>
</list-item>
<list-item id="u0070">
<p id="p0210">PyMOL, <ext-link ext-link-type="uri" id="intref0205" xlink:href="https://pymol.org/2/">https://pymol.org/2/</ext-link></p>
</list-item>
<list-item id="u0075">
<p id="p0215">RCSB Protein Data Bank, <ext-link ext-link-type="uri" id="intref0210" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link></p>
</list-item>
<list-item id="u0080">
<p id="p0220">UCSC Genome Browser, <ext-link ext-link-type="uri" id="intref0215" xlink:href="https://genome.ucsc.edu/">https://genome.ucsc.edu/</ext-link></p>
</list-item>
<list-item id="u0085">
<p id="p0225">YASARA, <ext-link ext-link-type="uri" id="intref0220" xlink:href="http://www.yasara.org">www.yasara.org</ext-link></p>
</list-item>
</list>
</p>
</sec>
<sec id="app4">
<title>Declaration of Interests</title>
<p id="p0230">Zöe Powis was an employee of Ambry Genetics. Slavé Petrovski is Vice-president and Head of Genome Analytics for AstraZeneca Centre for Genomics Research (CGR), Cambridge, UK.</p>
</sec>
<sec id="app2" sec-type="supplementary-material">
<title>Supplemental Data</title>
<p id="p0140">
<supplementary-material content-type="local-data" id="mmc1">
<caption>
<title>Document S1. Supplemental Note, Supplemental Material and Methods, Supplemental References, and Figures S1–S9</title>
</caption>
<media xlink:href="mmc1.pdf"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mmc2">
<caption>
<title>Table S1. Detailed Phenotypic and Genotypic Data of Individuals with FBXW11 Missense Variants</title>
</caption>
<media xlink:href="mmc2.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mmc3">
<caption>
<title>Document S2. Article plus Supplemental Data</title>
</caption>
<media xlink:href="mmc3.pdf"></media>
</supplementary-material>
</p>
</sec>
<ack id="ack0010">
<title>Acknowledgments</title>
<p>We would like to thank the families for their participation in our study. We are grateful to the West Midlands Regional Clinical Genetics Service and, in particular, Shaun Green for their help with sample processing and clinical genetic testing of UK families with AMC conditions. Data for individual 4 were obtained by the Duke Genome Sequencing clinic supported by the Duke University Health System. We would also like to thank Rebecca Spillmann (Duke Pediatric Medical Genetics, Duke University Medical Center, Durham, NC, USA), Ioana Cutcutache, Matthew Page (Translational Medicine, UCB Pharma, Slough, UK) and Martin Armstrong (Translational Medicine, UCB Pharma, Braine-l’Alleud, Belgium).</p>
<p>This work was supported by grants from <funding-source id="gs1">Baillie Gifford</funding-source>; <funding-source id="gs2">Visually Impaired Children Taking Action</funding-source> (VICTA) (<ext-link ext-link-type="uri" id="intref0125" xlink:href="http://www.victa.org.uk">www.victa.org.uk</ext-link>); <funding-source id="gs3">Microphthalmia, Anophthalmia and Coloboma Support</funding-source> (MACS) (<ext-link ext-link-type="uri" id="intref0130" xlink:href="http://www.macs.org.uk">www.macs.org.uk</ext-link>); <funding-source id="gs4">HEIF</funding-source> (Health Innovation Fund, Oxford Brookes University); <funding-source id="gs5">La Fondation de France</funding-source> (grant number 2015-00060235, 2015); <funding-source id="gs6">Fondation Maladies Rares and Retina France</funding-source>; <funding-source id="gs7">Fondazione Bambino Gesù</funding-source> (Vite Coraggiose); <funding-source id="gs8">E-Rare</funding-source> (NSEuroNet); <funding-source id="gs9">AIRC</funding-source> (the Italian Foundation for Cancer Research) (IG 21614); the <funding-source id="gs10">Italian Ministry of Health</funding-source> (Ricerca Corrente); and the <funding-source id="gs11">National Heart, Lung, and Blood Institute</funding-source> (R35 HL135742). French patients are part of the Rare Disease Cohort (RaDiCo)-AC-Oeil. RaDiCo is funded by the <funding-source id="gs12">French National Research Agency</funding-source> under the specific program “Investments for the Future,” cohort grant agreement ANR-10-COHO-0003. V.S. and J.S. were supported by <funding-source id="gs13">UCB Celltech</funding-source> and the <funding-source id="gs14">Duke Genome Sequencing Clinic</funding-source> grant. W.B.D. was supported by the US <funding-source id="gs15">National Institutes of Health</funding-source> under the <funding-source id="gs16">National Institute of Neurological Disorders and Stroke</funding-source> (NINDS) grant R01NS058721. R.M.Y. and S.W.W. were supported by an <funding-source id="gs17">MRC</funding-source> (Medical Research Council) Programme Grant (MR/L003775/1 to S.W.W. and G. Gestri) and a <funding-source id="gs18">Wellcome Trust</funding-source> Investigator Award (104682/Z/14/Z). The human embryonic and fetal material was provided by the <funding-source id="gs19">Joint MRC/Wellcome Trust</funding-source> (grant MR/R006237/1) Human Developmental Biology Resource (<ext-link ext-link-type="uri" id="intref0135" xlink:href="http://www.hdbr.org">www.hdbr.org</ext-link>).</p>
</ack>
<fn-group>
<fn fn-type="supplementary-material" id="app1">
<p id="p0135">Supplemental Data can be found online at <ext-link ext-link-type="uri" id="intref0140" xlink:href="https://doi.org/10.1016/j.ajhg.2019.07.005">https://doi.org/10.1016/j.ajhg.2019.07.005</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>